Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nfia
|
ENSMUSG00000028565.12 | nuclear factor I/A |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_97868947_97869135 | Nfia | 11078 | 0.275850 | 0.88 | 9.2e-19 | Click! |
chr4_97869213_97869416 | Nfia | 10805 | 0.276792 | 0.86 | 8.2e-17 | Click! |
chr4_97997227_97997378 | Nfia | 86269 | 0.093890 | 0.81 | 7.5e-14 | Click! |
chr4_97869602_97869753 | Nfia | 10442 | 0.278073 | 0.74 | 1.6e-10 | Click! |
chr4_98004455_98004658 | Nfia | 93523 | 0.083516 | 0.72 | 6.3e-10 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_19566788_19567409 | 72.46 |
Gm23330 |
predicted gene, 23330 |
6845 |
0.18 |
chr4_82404370_82404581 | 69.52 |
n-R5s188 |
nuclear encoded rRNA 5S 188 |
34935 |
0.2 |
chr4_33189135_33189836 | 64.07 |
Pm20d2 |
peptidase M20 domain containing 2 |
52 |
0.97 |
chr11_43548063_43548966 | 60.26 |
Ccnjl |
cyclin J-like |
19268 |
0.13 |
chr4_49041678_49042070 | 57.13 |
Plppr1 |
phospholipid phosphatase related 1 |
17399 |
0.23 |
chr6_39242951_39243777 | 52.30 |
Gm43479 |
predicted gene 43479 |
3250 |
0.2 |
chr7_31127074_31128340 | 51.54 |
Scn1b |
sodium channel, voltage-gated, type I, beta |
704 |
0.47 |
chr6_87621384_87621667 | 50.99 |
Gm34312 |
predicted gene, 34312 |
23778 |
0.1 |
chr2_14342056_14342277 | 50.03 |
Gm37697 |
predicted gene, 37697 |
3511 |
0.23 |
chr11_18115601_18116106 | 49.80 |
Gm12018 |
predicted gene 12018 |
19867 |
0.24 |
chr1_155233440_155234889 | 48.54 |
BC034090 |
cDNA sequence BC034090 |
1253 |
0.38 |
chr17_4974862_4975044 | 48.33 |
Arid1b |
AT rich interactive domain 1B (SWI-like) |
19379 |
0.2 |
chr14_21707021_21707750 | 47.21 |
Dupd1 |
dual specificity phosphatase and pro isomerase domain containing 1 |
4283 |
0.19 |
chr5_38882042_38882584 | 46.59 |
Clnk |
cytokine-dependent hematopoietic cell linker |
5501 |
0.3 |
chr1_106043127_106043301 | 46.45 |
Zcchc2 |
zinc finger, CCHC domain containing 2 |
31470 |
0.13 |
chr3_9173889_9174631 | 46.19 |
Zbtb10 |
zinc finger and BTB domain containing 10 |
76342 |
0.09 |
chr9_46350452_46350942 | 45.49 |
Gm31374 |
predicted gene, 31374 |
7922 |
0.12 |
chr14_101494013_101494504 | 44.91 |
Tbc1d4 |
TBC1 domain family, member 4 |
6850 |
0.27 |
chr10_41934443_41935500 | 43.90 |
Sesn1 |
sestrin 1 |
36598 |
0.15 |
chr9_119510823_119511314 | 43.70 |
Scn5a |
sodium channel, voltage-gated, type V, alpha |
51610 |
0.1 |
chr16_25016242_25016817 | 43.57 |
A230028O05Rik |
RIKEN cDNA A230028O05 gene |
43110 |
0.19 |
chr15_65593099_65593523 | 43.22 |
Gm49243 |
predicted gene, 49243 |
94837 |
0.08 |
chr17_64130305_64130818 | 43.00 |
Pja2 |
praja ring finger ubiquitin ligase 2 |
182470 |
0.03 |
chr19_5975566_5976108 | 42.52 |
Slc22a20 |
solute carrier family 22 (organic anion transporter), member 20 |
10306 |
0.07 |
chr4_120248711_120249520 | 42.21 |
Foxo6 |
forkhead box O6 |
38234 |
0.16 |
chr19_61225302_61226760 | 41.92 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr7_79194797_79195337 | 41.68 |
Mfge8 |
milk fat globule-EGF factor 8 protein |
46007 |
0.11 |
chr10_8348667_8348983 | 40.89 |
Ust |
uronyl-2-sulfotransferase |
46583 |
0.19 |
chr9_9583329_9583526 | 39.49 |
Gm46102 |
predicted gene, 46102 |
120 |
0.97 |
chr12_3236518_3237725 | 39.16 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr1_11458419_11458711 | 38.61 |
Gm38178 |
predicted gene, 38178 |
41647 |
0.16 |
chr4_72384628_72385513 | 38.58 |
Gm11235 |
predicted gene 11235 |
157596 |
0.04 |
chr14_24793475_24794060 | 38.58 |
Gm47906 |
predicted gene, 47906 |
39868 |
0.18 |
chr1_88594479_88594871 | 38.15 |
Gm19589 |
predicted gene, 19589 |
43158 |
0.12 |
chr18_45896851_45897467 | 37.98 |
A330093E20Rik |
RIKEN cDNA A330093E20 gene |
650 |
0.79 |
chr11_8513960_8514219 | 37.68 |
Tns3 |
tensin 3 |
31262 |
0.24 |
chr11_98509597_98509860 | 37.49 |
Ikzf3 |
IKAROS family zinc finger 3 |
20708 |
0.1 |
chr18_69576367_69576716 | 37.44 |
Tcf4 |
transcription factor 4 |
13206 |
0.24 |
chr15_38374820_38375240 | 36.90 |
Gm41307 |
predicted gene, 41307 |
29124 |
0.13 |
chr6_140689796_140690423 | 36.87 |
Gm11077 |
predicted gene 11077 |
39175 |
0.13 |
chr15_67898912_67899432 | 36.80 |
Gm49408 |
predicted gene, 49408 |
25344 |
0.23 |
chr11_17306067_17306478 | 35.72 |
Gm12015 |
predicted gene 12015 |
7853 |
0.23 |
chr16_84042025_84042426 | 35.62 |
Gm41481 |
predicted gene, 41481 |
15159 |
0.29 |
chr15_64402913_64403274 | 35.61 |
Gm30563 |
predicted gene, 30563 |
6714 |
0.23 |
chr4_87570443_87570874 | 35.52 |
Gm12604 |
predicted gene 12604 |
10131 |
0.3 |
chr13_15741859_15742225 | 35.39 |
Gm48408 |
predicted gene, 48408 |
28078 |
0.16 |
chr18_33692045_33692457 | 35.31 |
Epb41l4aos |
erythrocyte membrane protein band 4.1 like 4a, opposite strand |
102641 |
0.06 |
chr8_126667748_126668147 | 35.30 |
Irf2bp2 |
interferon regulatory factor 2 binding protein 2 |
73961 |
0.1 |
chr19_58822453_58822797 | 35.09 |
Hspa12a |
heat shock protein 12A |
504 |
0.77 |
chr19_21152233_21152408 | 35.08 |
AC106834.1 |
novel transcript |
18521 |
0.2 |
chr9_41697271_41698297 | 35.07 |
Gm48784 |
predicted gene, 48784 |
22730 |
0.14 |
chr12_113132495_113133476 | 35.02 |
Mta1 |
metastasis associated 1 |
1437 |
0.26 |
chr3_108085301_108086522 | 34.90 |
Gm12500 |
predicted gene 12500 |
65 |
0.8 |
chr8_84793716_84794468 | 34.61 |
Nfix |
nuclear factor I/X |
5932 |
0.1 |
chr9_42183474_42183866 | 34.50 |
4930546K05Rik |
RIKEN cDNA 4930546K05 gene |
25543 |
0.16 |
chr6_93150491_93150965 | 34.33 |
Gm5313 |
predicted gene 5313 |
12738 |
0.22 |
chr5_125148630_125148981 | 34.18 |
Ncor2 |
nuclear receptor co-repressor 2 |
23905 |
0.18 |
chr1_131770683_131771116 | 33.96 |
Slc26a9 |
solute carrier family 26, member 9 |
20408 |
0.14 |
chr2_154223254_154223780 | 33.77 |
Bpifb5 |
BPI fold containing family B, member 5 |
225 |
0.91 |
chr8_4206127_4207837 | 33.72 |
4932443L11Rik |
RIKEN cDNA 4932443L11 gene |
100 |
0.88 |
chr6_124915577_124916697 | 33.56 |
Ptms |
parathymosin |
608 |
0.37 |
chr3_39592375_39592677 | 33.41 |
Gm42781 |
predicted gene 42781 |
43533 |
0.15 |
chr3_62348500_62348904 | 33.39 |
Arhgef26 |
Rho guanine nucleotide exchange factor (GEF) 26 |
7601 |
0.24 |
chr1_14108426_14108817 | 33.23 |
Gm37400 |
predicted gene, 37400 |
4198 |
0.31 |
chr14_48083929_48084325 | 32.89 |
Gm6055 |
predicted gene 6055 |
4375 |
0.17 |
chr2_173257495_173258460 | 32.72 |
Pmepa1 |
prostate transmembrane protein, androgen induced 1 |
18212 |
0.17 |
chr14_55054973_55055741 | 32.70 |
Gm20687 |
predicted gene 20687 |
136 |
0.88 |
chr13_63901198_63901761 | 32.68 |
Ercc6l2 |
excision repair cross-complementing rodent repair deficiency, complementation group 6 like 2 |
7452 |
0.19 |
chr9_35108923_35109328 | 32.66 |
St3gal4 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
2458 |
0.22 |
chr16_77593811_77594374 | 32.65 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
264 |
0.83 |
chr13_15759168_15760299 | 32.63 |
Gm48408 |
predicted gene, 48408 |
10387 |
0.18 |
chr2_33130296_33131698 | 32.59 |
Garnl3 |
GTPase activating RANGAP domain-like 3 |
389 |
0.84 |
chr8_55115169_55115732 | 32.58 |
Gm8734 |
predicted gene 8734 |
33735 |
0.14 |
chr8_28299449_28299614 | 32.37 |
Gm8100 |
predicted gene 8100 |
113691 |
0.07 |
chr8_117935220_117935446 | 32.33 |
Gm10617 |
predicted gene 10617 |
133271 |
0.05 |
chr6_34660900_34661051 | 32.27 |
Gm13861 |
predicted gene 13861 |
7081 |
0.19 |
chr6_39319114_39319319 | 32.12 |
Slc37a3 |
solute carrier family 37 (glycerol-3-phosphate transporter), member 3 |
28134 |
0.14 |
chr5_111675302_111676044 | 32.08 |
Gm26897 |
predicted gene, 26897 |
58251 |
0.1 |
chr19_36534720_36535517 | 31.98 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
19521 |
0.2 |
chr19_48834305_48834713 | 31.79 |
Gm50436 |
predicted gene, 50436 |
23373 |
0.26 |
chr5_66979625_66979808 | 31.76 |
Limch1 |
LIM and calponin homology domains 1 |
2698 |
0.18 |
chr10_13171046_13171455 | 31.75 |
Zc2hc1b |
zinc finger, C2HC-type containing 1B |
6773 |
0.19 |
chr1_88254702_88255947 | 31.65 |
Mroh2a |
maestro heat-like repeat family member 2A |
2434 |
0.15 |
chr16_50309458_50309740 | 31.63 |
Bbx |
bobby sox HMG box containing |
21394 |
0.27 |
chr16_74055287_74055476 | 31.55 |
Gm22163 |
predicted gene, 22163 |
3652 |
0.23 |
chr16_96620455_96620678 | 31.49 |
Dscam |
DS cell adhesion molecule |
2188 |
0.34 |
chr14_79873103_79873464 | 31.43 |
Gm10845 |
predicted gene 10845 |
4107 |
0.2 |
chr18_8054510_8054913 | 31.38 |
Gm4833 |
predicted gene 4833 |
3508 |
0.33 |
chr1_93184157_93184466 | 31.34 |
Crocc2 |
ciliary rootlet coiled-coil, rootletin family member 2 |
15586 |
0.12 |
chr15_78835129_78836581 | 31.33 |
Cdc42ep1 |
CDC42 effector protein (Rho GTPase binding) 1 |
6769 |
0.09 |
chr3_55248555_55248739 | 31.21 |
Dclk1 |
doublecortin-like kinase 1 |
1368 |
0.44 |
chr1_161224874_161225204 | 31.14 |
Gm6185 |
predicted gene 6185 |
24230 |
0.13 |
chr15_31989572_31989923 | 31.12 |
Gm49285 |
predicted gene, 49285 |
60204 |
0.14 |
chr13_34129793_34130880 | 31.09 |
Tubb2b |
tubulin, beta 2B class IIB |
18 |
0.96 |
chr2_49840515_49840945 | 30.98 |
Lypd6b |
LY6/PLAUR domain containing 6B |
640 |
0.78 |
chr3_41198341_41198531 | 30.81 |
Gm40038 |
predicted gene, 40038 |
25773 |
0.2 |
chr19_41101308_41101736 | 30.77 |
Opalin |
oligodendrocytic myelin paranodal and inner loop protein |
24409 |
0.2 |
chr15_66353929_66354089 | 30.65 |
Gm19077 |
predicted gene, 19077 |
4475 |
0.23 |
chr10_13446842_13447237 | 30.56 |
Phactr2 |
phosphatase and actin regulator 2 |
27373 |
0.19 |
chr9_83145596_83146040 | 30.48 |
Gm29054 |
predicted gene 29054 |
97 |
0.9 |
chr11_79729572_79730060 | 30.36 |
Mir365-2 |
microRNA 365-2 |
3416 |
0.17 |
chr1_167660571_167661124 | 30.26 |
Lmx1a |
LIM homeobox transcription factor 1 alpha |
28390 |
0.21 |
chr15_19162255_19162444 | 30.25 |
Gm35496 |
predicted gene, 35496 |
23024 |
0.19 |
chr17_13654565_13655321 | 30.18 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
13948 |
0.15 |
chr1_18181257_18181437 | 30.14 |
Crisp4 |
cysteine-rich secretory protein 4 |
35445 |
0.14 |
chr12_26405116_26405608 | 30.04 |
Rnf144a |
ring finger protein 144A |
1085 |
0.45 |
chr4_97926945_97927279 | 29.83 |
Nfia |
nuclear factor I/A |
16079 |
0.28 |
chr11_90382103_90382369 | 29.76 |
Hlf |
hepatic leukemia factor |
301 |
0.94 |
chr4_87461244_87461952 | 29.75 |
Gm23154 |
predicted gene, 23154 |
29326 |
0.24 |
chr4_64282612_64282851 | 29.75 |
Gm11217 |
predicted gene 11217 |
6128 |
0.31 |
chr2_172468408_172468770 | 29.69 |
Fam209 |
family with sequence similarity 209 |
3931 |
0.16 |
chr8_40880742_40881149 | 29.56 |
Slc7a2 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
5997 |
0.17 |
chr9_62526297_62526844 | 29.50 |
Coro2b |
coronin, actin binding protein, 2B |
6134 |
0.23 |
chr12_56415275_56415462 | 29.49 |
Gm18027 |
predicted gene, 18027 |
4811 |
0.2 |
chr4_62942067_62942245 | 29.49 |
Gm11480 |
predicted gene 11480 |
2244 |
0.22 |
chr16_85748095_85748429 | 29.46 |
Adamts1 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1 |
51376 |
0.15 |
chr2_33753581_33754617 | 29.37 |
Mvb12b |
multivesicular body subunit 12B |
34660 |
0.14 |
chr19_60463855_60464221 | 29.26 |
Prlhr |
prolactin releasing hormone receptor |
4266 |
0.29 |
chr3_139885937_139886924 | 29.07 |
Gm43678 |
predicted gene 43678 |
73666 |
0.11 |
chr18_3666457_3667025 | 29.06 |
Gm50091 |
predicted gene, 50091 |
50460 |
0.14 |
chr1_75786505_75786826 | 28.83 |
Gm5257 |
predicted gene 5257 |
150275 |
0.03 |
chr8_12947304_12948554 | 28.73 |
Mcf2l |
mcf.2 transforming sequence-like |
10 |
0.49 |
chr1_192789049_192789578 | 28.73 |
Hhat |
hedgehog acyltransferase |
18090 |
0.14 |
chr8_123648250_123648884 | 28.67 |
Rhou |
ras homolog family member U |
5362 |
0.04 |
chr12_78098700_78099225 | 28.64 |
Gm24994 |
predicted gene, 24994 |
66584 |
0.11 |
chr17_72042983_72043261 | 28.62 |
Gm49924 |
predicted gene, 49924 |
116092 |
0.06 |
chr6_35988986_35989206 | 28.61 |
Gm23273 |
predicted gene, 23273 |
13766 |
0.27 |
chr7_99267195_99268129 | 28.51 |
Map6 |
microtubule-associated protein 6 |
173 |
0.76 |
chrX_19904603_19905052 | 28.46 |
Gm5384 |
predicted gene 5384 |
11170 |
0.23 |
chr13_32531016_32531402 | 28.45 |
Gm48073 |
predicted gene, 48073 |
5206 |
0.28 |
chr10_70717060_70717414 | 28.40 |
Gm33979 |
predicted gene, 33979 |
21607 |
0.18 |
chr18_12643212_12644484 | 28.37 |
Ttc39c |
tetratricopeptide repeat domain 39C |
486 |
0.46 |
chr15_50997219_50997761 | 28.30 |
Gm48913 |
predicted gene, 48913 |
99851 |
0.08 |
chr12_82415654_82416073 | 28.20 |
Sipa1l1 |
signal-induced proliferation-associated 1 like 1 |
4752 |
0.3 |
chr11_66882367_66882552 | 28.19 |
Pirt |
phosphoinositide-interacting regulator of transient receptor potential channels |
29522 |
0.18 |
chr6_99971402_99971775 | 28.10 |
Gm33201 |
predicted gene, 33201 |
19627 |
0.18 |
chr5_134014531_134015255 | 28.02 |
1700030N18Rik |
RIKEN cDNA 1700030N18 gene |
76558 |
0.08 |
chr7_55401522_55401727 | 27.99 |
Gm9367 |
predicted gene 9367 |
60445 |
0.13 |
chr8_83667823_83669013 | 27.97 |
Ptger1 |
prostaglandin E receptor 1 (subtype EP1) |
1276 |
0.29 |
chr1_9629816_9630624 | 27.82 |
2610203C22Rik |
RIKEN cDNA 2610203C22 gene |
872 |
0.51 |
chr5_25613821_25614264 | 27.79 |
Gm43972 |
predicted gene, 43972 |
45767 |
0.1 |
chr12_21136010_21136733 | 27.79 |
Asap2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
24417 |
0.18 |
chr7_80121190_80121624 | 27.76 |
Idh2 |
isocitrate dehydrogenase 2 (NADP+), mitochondrial |
6015 |
0.12 |
chr18_54452393_54453295 | 27.72 |
Gm50361 |
predicted gene, 50361 |
23921 |
0.19 |
chr6_113795101_113795729 | 27.57 |
Gm44167 |
predicted gene, 44167 |
4269 |
0.16 |
chr17_86266136_86266331 | 27.54 |
2010106C02Rik |
RIKEN cDNA 2010106C02 gene |
20945 |
0.23 |
chr15_21179717_21180088 | 27.44 |
Gm38234 |
predicted gene, 38234 |
255 |
0.95 |
chr8_123235522_123236588 | 27.43 |
Spata2l |
spermatogenesis associated 2-like |
152 |
0.84 |
chr19_38054215_38055320 | 27.39 |
I830134H01Rik |
RIKEN cDNA I830134H01 gene |
239 |
0.48 |
chr1_119504196_119505478 | 27.37 |
Ralb |
v-ral simian leukemia viral oncogene B |
43 |
0.96 |
chr15_12640961_12641126 | 27.36 |
F830212C03Rik |
RIKEN cDNA F830212C03 gene |
5697 |
0.2 |
chr2_7089567_7089791 | 27.31 |
Celf2 |
CUGBP, Elav-like family member 2 |
8366 |
0.29 |
chr4_111597201_111597750 | 27.30 |
Agbl4 |
ATP/GTP binding protein-like 4 |
30750 |
0.22 |
chr10_85597967_85598468 | 27.23 |
Btbd11 |
BTB (POZ) domain containing 11 |
184 |
0.96 |
chr13_12650037_12651101 | 27.22 |
Gpr137b-ps |
G protein-coupled receptor 137B, pseudogene |
181 |
0.91 |
chr7_97446538_97446946 | 27.19 |
Kctd14 |
potassium channel tetramerisation domain containing 14 |
4581 |
0.16 |
chr4_33524476_33525134 | 27.11 |
Gm11935 |
predicted gene 11935 |
71916 |
0.1 |
chr7_89115680_89116002 | 27.09 |
Tmem135 |
transmembrane protein 135 |
29656 |
0.22 |
chr7_6729309_6729829 | 27.06 |
Peg3 |
paternally expressed 3 |
850 |
0.28 |
chr9_22188003_22188542 | 27.04 |
Zfp872 |
zinc finger protein 872 |
104 |
0.91 |
chr3_68824497_68825036 | 26.97 |
Gm7270 |
predicted gene 7270 |
21313 |
0.12 |
chr12_54286915_54287542 | 26.91 |
Gm47552 |
predicted gene, 47552 |
29787 |
0.13 |
chr1_41652721_41653091 | 26.91 |
Gm28634 |
predicted gene 28634 |
123363 |
0.06 |
chr9_40537844_40538246 | 26.90 |
Gramd1b |
GRAM domain containing 1B |
6662 |
0.13 |
chr12_82025817_82026338 | 26.84 |
Gm49749 |
predicted gene, 49749 |
25809 |
0.19 |
chr15_7480234_7480458 | 26.72 |
Egflam |
EGF-like, fibronectin type III and laminin G domains |
81951 |
0.09 |
chr13_63918756_63919481 | 26.72 |
Ercc6l2 |
excision repair cross-complementing rodent repair deficiency, complementation group 6 like 2 |
25091 |
0.15 |
chr5_125221795_125222188 | 26.61 |
Ncor2 |
nuclear receptor co-repressor 2 |
42772 |
0.12 |
chr11_46065406_46066070 | 26.60 |
Adam19 |
a disintegrin and metallopeptidase domain 19 (meltrin beta) |
9680 |
0.13 |
chr12_76955089_76955421 | 26.59 |
Max |
Max protein |
846 |
0.57 |
chr1_38835547_38836894 | 26.53 |
Lonrf2 |
LON peptidase N-terminal domain and ring finger 2 |
154 |
0.95 |
chr11_88582890_88583759 | 26.44 |
Msi2 |
musashi RNA-binding protein 2 |
6823 |
0.27 |
chr3_105538840_105539458 | 26.31 |
Gm43847 |
predicted gene 43847 |
36242 |
0.16 |
chr12_79511638_79512170 | 26.29 |
Rad51b |
RAD51 paralog B |
184551 |
0.03 |
chr3_108327891_108328181 | 26.26 |
Sort1 |
sortilin 1 |
27431 |
0.07 |
chr13_13393240_13394314 | 26.20 |
Gpr137b |
G protein-coupled receptor 137B |
153 |
0.93 |
chr7_125847014_125847189 | 26.20 |
D430042O09Rik |
RIKEN cDNA D430042O09 gene |
13581 |
0.26 |
chr10_94990705_94991025 | 26.17 |
Gm48867 |
predicted gene, 48867 |
8577 |
0.22 |
chr12_82056743_82057212 | 26.16 |
Gm49749 |
predicted gene, 49749 |
56709 |
0.12 |
chr14_78383257_78383728 | 26.12 |
Gm26197 |
predicted gene, 26197 |
72152 |
0.09 |
chr3_145083052_145083382 | 26.09 |
Clca2 |
chloride channel accessory 2 |
15887 |
0.18 |
chr8_23596316_23596734 | 26.09 |
Zmat4 |
zinc finger, matrin type 4 |
39494 |
0.19 |
chr2_140839882_140840261 | 26.09 |
Calr-ps |
calreticulin, pseudogene |
116178 |
0.06 |
chr6_25686769_25687229 | 26.01 |
Gpr37 |
G protein-coupled receptor 37 |
2793 |
0.38 |
chr2_164874193_164874753 | 25.95 |
Pcif1 |
PDX1 C-terminal inhibiting factor 1 |
4831 |
0.1 |
chr18_61900936_61901333 | 25.84 |
Ablim3 |
actin binding LIM protein family, member 3 |
10689 |
0.19 |
chr10_96720220_96720718 | 25.77 |
Gm48507 |
predicted gene, 48507 |
8662 |
0.21 |
chr2_71719662_71719958 | 25.71 |
Platr26 |
pluripotency associated transcript 26 |
393 |
0.8 |
chr6_144419162_144419621 | 25.67 |
Sox5os2 |
SRY (sex determining region Y)-box 5, opposite strand 2 |
61834 |
0.15 |
chr18_81051932_81052083 | 25.66 |
Gm50424 |
predicted gene, 50424 |
5183 |
0.17 |
chr1_160693111_160693437 | 25.65 |
Gm37328 |
predicted gene, 37328 |
33407 |
0.1 |
chr4_133659945_133660763 | 25.64 |
Zdhhc18 |
zinc finger, DHHC domain containing 18 |
10200 |
0.12 |
chr1_161576055_161576222 | 25.63 |
Gm25488 |
predicted gene, 25488 |
23472 |
0.2 |
chr16_9753013_9753397 | 25.63 |
Grin2a |
glutamate receptor, ionotropic, NMDA2A (epsilon 1) |
44128 |
0.2 |
chr5_133889923_133890326 | 25.61 |
Gm2404 |
predicted gene 2404 |
29878 |
0.2 |
chr6_93232662_93232826 | 25.56 |
Gm44220 |
predicted gene, 44220 |
8976 |
0.23 |
chr5_24597183_24597664 | 25.49 |
Smarcd3 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 |
434 |
0.68 |
chr17_45312981_45313245 | 25.44 |
Cdc5l |
cell division cycle 5-like (S. pombe) |
102571 |
0.05 |
chr16_30231975_30232184 | 25.38 |
Gm49645 |
predicted gene, 49645 |
23073 |
0.12 |
chr10_13090310_13090875 | 25.28 |
Plagl1 |
pleiomorphic adenoma gene-like 1 |
99 |
0.97 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
29.6 | 88.9 | GO:0021564 | vagus nerve development(GO:0021564) |
22.3 | 66.9 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
21.5 | 64.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
18.1 | 54.3 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
17.9 | 71.7 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
17.9 | 71.5 | GO:0060486 | Clara cell differentiation(GO:0060486) |
16.9 | 50.7 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
16.2 | 48.7 | GO:0033058 | directional locomotion(GO:0033058) |
15.5 | 31.0 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
15.2 | 30.4 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
15.2 | 45.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
14.6 | 29.1 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
14.3 | 28.6 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
13.9 | 41.6 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
13.6 | 40.8 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
13.5 | 40.5 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
13.4 | 40.1 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
13.2 | 26.4 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
13.0 | 38.9 | GO:0001927 | exocyst assembly(GO:0001927) |
12.9 | 25.9 | GO:0072235 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
12.9 | 77.5 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
12.8 | 25.6 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
12.8 | 25.5 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) |
12.7 | 63.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
12.6 | 101.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
12.3 | 98.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
12.2 | 36.6 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
12.2 | 12.2 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
12.1 | 48.5 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
12.1 | 24.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
11.9 | 47.7 | GO:0046959 | habituation(GO:0046959) |
11.9 | 59.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
11.8 | 35.5 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
11.7 | 35.1 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
11.4 | 45.8 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
11.2 | 22.4 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
11.2 | 22.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
11.1 | 22.1 | GO:0031223 | auditory behavior(GO:0031223) |
11.1 | 33.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
10.9 | 43.6 | GO:0022038 | corpus callosum development(GO:0022038) |
10.9 | 65.1 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
10.9 | 65.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
10.4 | 41.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
10.2 | 30.7 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
9.9 | 19.8 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
9.9 | 29.6 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
9.9 | 49.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
9.8 | 39.3 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
9.7 | 9.7 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
9.7 | 77.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
9.6 | 19.2 | GO:0061642 | chemoattraction of axon(GO:0061642) |
9.4 | 65.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
9.4 | 65.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
9.3 | 9.3 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
9.3 | 28.0 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
9.3 | 37.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
9.3 | 9.3 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
9.3 | 9.3 | GO:1903375 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
9.2 | 46.2 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
9.2 | 9.2 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
9.2 | 27.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
9.0 | 27.1 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
9.0 | 27.0 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
8.8 | 26.3 | GO:0021871 | forebrain regionalization(GO:0021871) |
8.7 | 26.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
8.6 | 17.2 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
8.6 | 17.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
8.5 | 51.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
8.5 | 8.5 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
8.4 | 25.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
8.4 | 33.5 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
8.4 | 66.9 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
8.3 | 33.4 | GO:0030091 | protein repair(GO:0030091) |
8.3 | 33.2 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
8.2 | 24.7 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
8.2 | 32.7 | GO:0007412 | axon target recognition(GO:0007412) |
8.1 | 32.5 | GO:0090427 | activation of meiosis(GO:0090427) |
8.1 | 64.9 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
8.0 | 24.1 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
8.0 | 23.9 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
8.0 | 23.9 | GO:0021586 | pons maturation(GO:0021586) |
7.9 | 23.7 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
7.9 | 39.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
7.8 | 86.2 | GO:0008038 | neuron recognition(GO:0008038) |
7.8 | 7.8 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
7.8 | 15.6 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
7.7 | 15.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
7.7 | 23.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
7.7 | 23.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
7.7 | 30.7 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
7.7 | 138.0 | GO:0060074 | synapse maturation(GO:0060074) |
7.6 | 7.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
7.6 | 30.5 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
7.5 | 30.0 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
7.5 | 22.5 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
7.5 | 30.0 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
7.5 | 37.4 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
7.5 | 14.9 | GO:0008355 | olfactory learning(GO:0008355) |
7.4 | 7.4 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
7.4 | 22.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
7.4 | 14.7 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
7.4 | 44.2 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
7.3 | 44.0 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
7.3 | 58.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
7.3 | 36.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
7.2 | 21.6 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
7.2 | 28.7 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
7.1 | 56.7 | GO:0071625 | vocalization behavior(GO:0071625) |
7.0 | 21.1 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
7.0 | 14.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
7.0 | 20.9 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
6.9 | 20.6 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
6.8 | 34.2 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
6.8 | 13.7 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
6.8 | 41.0 | GO:0099515 | actin filament-based transport(GO:0099515) |
6.8 | 6.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
6.8 | 54.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
6.7 | 13.5 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
6.7 | 20.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
6.7 | 13.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
6.7 | 26.7 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
6.6 | 26.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
6.6 | 39.7 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
6.6 | 19.7 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
6.6 | 65.8 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
6.6 | 6.6 | GO:0050883 | medulla oblongata development(GO:0021550) musculoskeletal movement, spinal reflex action(GO:0050883) |
6.5 | 13.0 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
6.4 | 51.4 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
6.4 | 19.2 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
6.3 | 6.3 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
6.3 | 6.3 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
6.3 | 6.3 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
6.3 | 12.6 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
6.3 | 6.3 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
6.2 | 12.5 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
6.2 | 6.2 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
6.2 | 31.0 | GO:0009115 | xanthine catabolic process(GO:0009115) |
6.2 | 31.0 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
6.1 | 18.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
6.1 | 24.5 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
6.1 | 18.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
6.1 | 6.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
6.0 | 24.1 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
6.0 | 12.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
6.0 | 12.0 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
6.0 | 23.8 | GO:0080154 | regulation of fertilization(GO:0080154) |
6.0 | 11.9 | GO:0060166 | olfactory pit development(GO:0060166) |
5.9 | 11.9 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
5.9 | 23.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
5.9 | 11.8 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
5.9 | 11.8 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
5.9 | 5.9 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
5.9 | 82.0 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
5.8 | 5.8 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
5.8 | 17.3 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
5.8 | 46.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
5.7 | 28.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
5.7 | 5.7 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
5.7 | 17.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
5.7 | 22.8 | GO:0070842 | aggresome assembly(GO:0070842) |
5.7 | 28.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
5.7 | 62.5 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
5.7 | 90.8 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
5.7 | 17.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
5.6 | 11.3 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
5.6 | 16.9 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
5.6 | 5.6 | GO:1901166 | neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
5.6 | 16.7 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
5.5 | 21.8 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
5.4 | 5.4 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
5.4 | 16.3 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
5.4 | 21.6 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
5.4 | 16.2 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
5.4 | 21.6 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
5.4 | 32.4 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
5.4 | 26.9 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
5.4 | 21.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
5.3 | 85.5 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
5.3 | 10.7 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
5.3 | 10.7 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
5.3 | 16.0 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
5.3 | 74.6 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
5.3 | 10.6 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
5.3 | 15.9 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
5.3 | 89.9 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
5.3 | 5.3 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
5.2 | 110.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
5.2 | 15.7 | GO:0060437 | lung growth(GO:0060437) |
5.2 | 10.5 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
5.2 | 5.2 | GO:1902837 | amino acid import into cell(GO:1902837) |
5.2 | 15.6 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
5.2 | 5.2 | GO:0060594 | mammary gland specification(GO:0060594) |
5.2 | 31.0 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
5.2 | 5.2 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
5.1 | 30.9 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
5.1 | 25.6 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
5.1 | 25.5 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
5.1 | 20.4 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
5.1 | 15.3 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
5.1 | 35.6 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
5.1 | 10.1 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
5.0 | 10.1 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
5.0 | 5.0 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
5.0 | 25.0 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
5.0 | 29.9 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
5.0 | 24.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
4.9 | 14.8 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
4.9 | 4.9 | GO:0051794 | regulation of catagen(GO:0051794) |
4.9 | 4.9 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
4.9 | 14.7 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
4.9 | 4.9 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
4.7 | 47.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
4.7 | 52.0 | GO:0001964 | startle response(GO:0001964) |
4.7 | 4.7 | GO:0030501 | positive regulation of bone mineralization(GO:0030501) |
4.7 | 4.7 | GO:0060278 | regulation of ovulation(GO:0060278) |
4.7 | 14.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
4.7 | 14.1 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
4.6 | 4.6 | GO:0048570 | notochord morphogenesis(GO:0048570) |
4.6 | 9.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
4.6 | 13.8 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
4.6 | 9.2 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
4.6 | 23.0 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
4.6 | 9.2 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
4.6 | 13.8 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
4.6 | 9.2 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
4.6 | 4.6 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
4.6 | 9.1 | GO:1903416 | response to glycoside(GO:1903416) |
4.5 | 9.0 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
4.5 | 18.0 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
4.5 | 44.7 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
4.5 | 8.9 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
4.4 | 17.8 | GO:0010996 | response to auditory stimulus(GO:0010996) |
4.4 | 39.5 | GO:0021542 | dentate gyrus development(GO:0021542) |
4.4 | 8.7 | GO:0071895 | odontoblast differentiation(GO:0071895) |
4.4 | 13.1 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
4.3 | 21.7 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
4.3 | 21.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
4.3 | 8.6 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
4.3 | 17.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
4.3 | 8.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
4.3 | 12.8 | GO:0032808 | lacrimal gland development(GO:0032808) |
4.2 | 25.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
4.1 | 4.1 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
4.1 | 12.4 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
4.1 | 37.2 | GO:0003417 | growth plate cartilage development(GO:0003417) |
4.1 | 4.1 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
4.1 | 12.4 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
4.1 | 12.4 | GO:0006868 | glutamine transport(GO:0006868) |
4.1 | 4.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
4.1 | 4.1 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
4.1 | 4.1 | GO:0007619 | courtship behavior(GO:0007619) |
4.1 | 16.3 | GO:0090500 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) endocardial cushion to mesenchymal transition(GO:0090500) |
4.1 | 36.7 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
4.1 | 12.2 | GO:0045759 | negative regulation of action potential(GO:0045759) |
4.1 | 20.3 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
4.1 | 4.1 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
4.0 | 174.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
4.0 | 16.2 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
4.0 | 40.4 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
4.0 | 302.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
4.0 | 8.0 | GO:0061055 | myotome development(GO:0061055) |
4.0 | 11.9 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
4.0 | 11.9 | GO:0032513 | regulation of protein phosphatase type 2B activity(GO:0032512) negative regulation of protein phosphatase type 2B activity(GO:0032513) |
3.9 | 11.8 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
3.9 | 11.8 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
3.9 | 7.9 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
3.9 | 15.7 | GO:1903726 | negative regulation of phospholipid metabolic process(GO:1903726) |
3.9 | 74.3 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
3.9 | 3.9 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
3.9 | 3.9 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
3.9 | 11.6 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
3.9 | 11.6 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
3.9 | 11.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
3.9 | 46.4 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
3.9 | 15.4 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
3.9 | 65.5 | GO:0021954 | central nervous system neuron development(GO:0021954) |
3.8 | 7.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
3.8 | 15.4 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
3.8 | 11.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
3.8 | 7.7 | GO:0070375 | ERK5 cascade(GO:0070375) |
3.8 | 3.8 | GO:1990035 | calcium ion import into cell(GO:1990035) |
3.8 | 38.1 | GO:0003334 | keratinocyte development(GO:0003334) |
3.8 | 19.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
3.8 | 7.5 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
3.8 | 3.8 | GO:0090135 | actin filament branching(GO:0090135) |
3.8 | 3.8 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
3.7 | 18.7 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
3.7 | 3.7 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
3.7 | 7.4 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
3.7 | 14.9 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
3.7 | 14.8 | GO:0051963 | regulation of synapse assembly(GO:0051963) |
3.7 | 33.4 | GO:0097120 | receptor localization to synapse(GO:0097120) |
3.7 | 7.4 | GO:0048371 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
3.7 | 14.7 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
3.7 | 7.3 | GO:0061525 | hindgut development(GO:0061525) |
3.7 | 7.3 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
3.7 | 11.0 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
3.6 | 18.2 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
3.6 | 29.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
3.6 | 3.6 | GO:0099623 | regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
3.6 | 14.5 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
3.6 | 3.6 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
3.6 | 3.6 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
3.6 | 3.6 | GO:0035995 | detection of muscle stretch(GO:0035995) |
3.6 | 10.7 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
3.6 | 28.4 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
3.5 | 7.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
3.5 | 7.1 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
3.5 | 3.5 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
3.5 | 35.0 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
3.5 | 24.4 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
3.5 | 27.9 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
3.5 | 3.5 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
3.5 | 13.9 | GO:0030222 | eosinophil differentiation(GO:0030222) |
3.5 | 6.9 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
3.4 | 6.9 | GO:1904023 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
3.4 | 6.9 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
3.4 | 10.3 | GO:0014878 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
3.4 | 13.7 | GO:0014028 | notochord formation(GO:0014028) |
3.4 | 10.3 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
3.4 | 6.8 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
3.4 | 6.8 | GO:0044849 | estrous cycle(GO:0044849) |
3.4 | 3.4 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
3.4 | 17.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
3.4 | 13.5 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
3.4 | 6.7 | GO:0060618 | nipple development(GO:0060618) |
3.4 | 16.8 | GO:0060433 | bronchus development(GO:0060433) lobar bronchus development(GO:0060482) |
3.4 | 23.5 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
3.4 | 23.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
3.3 | 3.3 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
3.3 | 70.2 | GO:0035412 | regulation of catenin import into nucleus(GO:0035412) |
3.3 | 13.3 | GO:0019695 | choline metabolic process(GO:0019695) |
3.3 | 56.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
3.3 | 3.3 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
3.3 | 13.2 | GO:0051775 | response to redox state(GO:0051775) |
3.3 | 13.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
3.3 | 3.3 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
3.3 | 13.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
3.3 | 36.1 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
3.3 | 6.6 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
3.3 | 3.3 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
3.2 | 279.2 | GO:0097485 | neuron projection guidance(GO:0097485) |
3.2 | 3.2 | GO:0072132 | mesenchyme morphogenesis(GO:0072132) |
3.2 | 6.4 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
3.2 | 3.2 | GO:0035425 | autocrine signaling(GO:0035425) |
3.2 | 3.2 | GO:0051451 | myoblast migration(GO:0051451) |
3.2 | 9.6 | GO:0007258 | JUN phosphorylation(GO:0007258) |
3.2 | 9.6 | GO:0003383 | apical constriction(GO:0003383) |
3.2 | 12.8 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
3.2 | 3.2 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
3.2 | 9.5 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
3.2 | 6.3 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
3.2 | 15.8 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
3.1 | 37.7 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
3.1 | 3.1 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
3.1 | 12.5 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
3.1 | 9.3 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
3.1 | 6.2 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
3.1 | 9.3 | GO:0060440 | trachea formation(GO:0060440) |
3.1 | 21.6 | GO:0032060 | bleb assembly(GO:0032060) |
3.1 | 15.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
3.1 | 12.3 | GO:0003416 | endochondral bone growth(GO:0003416) |
3.1 | 36.9 | GO:0090083 | inclusion body assembly(GO:0070841) regulation of inclusion body assembly(GO:0090083) |
3.1 | 3.1 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
3.1 | 18.4 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
3.1 | 6.1 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
3.0 | 15.2 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
3.0 | 9.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
3.0 | 3.0 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
3.0 | 6.0 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
3.0 | 12.0 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
3.0 | 3.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
3.0 | 6.0 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
3.0 | 11.9 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
3.0 | 3.0 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
3.0 | 8.9 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
3.0 | 8.9 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
3.0 | 8.9 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
3.0 | 5.9 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
2.9 | 2.9 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
2.9 | 8.8 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
2.9 | 17.6 | GO:0006105 | succinate metabolic process(GO:0006105) |
2.9 | 11.7 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
2.9 | 166.4 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
2.9 | 8.7 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
2.9 | 2.9 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
2.9 | 5.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
2.9 | 8.7 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
2.9 | 2.9 | GO:1901142 | insulin metabolic process(GO:1901142) |
2.9 | 11.6 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
2.9 | 2.9 | GO:0021511 | spinal cord patterning(GO:0021511) |
2.9 | 11.6 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
2.9 | 5.8 | GO:0051013 | microtubule severing(GO:0051013) |
2.9 | 2.9 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) |
2.9 | 2.9 | GO:0071655 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
2.9 | 8.6 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
2.8 | 2.8 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
2.8 | 5.7 | GO:0070528 | protein kinase C signaling(GO:0070528) |
2.8 | 27.9 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
2.8 | 5.6 | GO:0051665 | membrane raft localization(GO:0051665) |
2.8 | 5.6 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
2.8 | 11.1 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
2.8 | 8.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
2.8 | 16.6 | GO:0001975 | response to amphetamine(GO:0001975) |
2.8 | 13.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
2.8 | 13.8 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
2.7 | 13.7 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
2.7 | 2.7 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
2.7 | 2.7 | GO:0007525 | somatic muscle development(GO:0007525) |
2.7 | 8.2 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
2.7 | 5.4 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
2.7 | 5.4 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
2.7 | 5.4 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
2.7 | 8.1 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
2.7 | 2.7 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
2.7 | 13.5 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
2.7 | 8.1 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
2.7 | 5.4 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
2.7 | 8.0 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
2.7 | 26.5 | GO:0022029 | telencephalon cell migration(GO:0022029) |
2.7 | 8.0 | GO:0097503 | sialylation(GO:0097503) |
2.6 | 7.9 | GO:0033227 | dsRNA transport(GO:0033227) |
2.6 | 2.6 | GO:0030421 | defecation(GO:0030421) |
2.6 | 10.6 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
2.6 | 2.6 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
2.6 | 5.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
2.6 | 2.6 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
2.6 | 5.2 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
2.6 | 2.6 | GO:0072053 | renal inner medulla development(GO:0072053) |
2.6 | 20.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
2.6 | 7.8 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
2.6 | 20.7 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
2.6 | 7.7 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
2.6 | 36.1 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
2.6 | 7.7 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
2.6 | 2.6 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
2.5 | 5.1 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
2.5 | 2.5 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
2.5 | 5.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
2.5 | 10.2 | GO:1903998 | regulation of eating behavior(GO:1903998) |
2.5 | 10.1 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
2.5 | 15.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
2.5 | 7.6 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
2.5 | 15.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
2.5 | 5.0 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
2.5 | 5.0 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
2.5 | 7.5 | GO:0015705 | iodide transport(GO:0015705) |
2.5 | 2.5 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
2.5 | 9.9 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
2.5 | 7.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
2.5 | 7.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
2.4 | 7.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
2.4 | 9.7 | GO:0033762 | response to glucagon(GO:0033762) |
2.4 | 4.8 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
2.4 | 16.9 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
2.4 | 4.8 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
2.4 | 12.0 | GO:0034776 | response to histamine(GO:0034776) |
2.4 | 4.8 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
2.4 | 28.7 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
2.4 | 4.8 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
2.4 | 4.8 | GO:0050807 | regulation of synapse organization(GO:0050807) |
2.4 | 26.2 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
2.4 | 9.5 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
2.4 | 4.7 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
2.4 | 7.1 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
2.4 | 11.8 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
2.4 | 193.1 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
2.4 | 4.7 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
2.4 | 7.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
2.4 | 11.8 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
2.4 | 2.4 | GO:0006551 | leucine metabolic process(GO:0006551) |
2.3 | 23.5 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
2.3 | 7.0 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
2.3 | 9.3 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
2.3 | 34.8 | GO:0016486 | peptide hormone processing(GO:0016486) |
2.3 | 4.6 | GO:0038001 | paracrine signaling(GO:0038001) |
2.3 | 11.5 | GO:0015884 | folic acid transport(GO:0015884) |
2.3 | 27.5 | GO:0015858 | nucleoside transport(GO:0015858) |
2.3 | 4.6 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
2.3 | 11.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
2.3 | 4.5 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
2.3 | 24.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
2.3 | 6.8 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
2.3 | 2.3 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
2.2 | 4.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
2.2 | 4.5 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
2.2 | 6.7 | GO:0060068 | vagina development(GO:0060068) |
2.2 | 2.2 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
2.2 | 15.6 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
2.2 | 15.6 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
2.2 | 2.2 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
2.2 | 6.6 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
2.2 | 2.2 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
2.2 | 6.5 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
2.2 | 2.2 | GO:0010755 | regulation of plasminogen activation(GO:0010755) negative regulation of plasminogen activation(GO:0010757) |
2.2 | 6.5 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
2.2 | 4.3 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
2.2 | 4.3 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
2.2 | 2.2 | GO:0045226 | hyaluranon cable assembly(GO:0036118) extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
2.1 | 4.3 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
2.1 | 4.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
2.1 | 21.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
2.1 | 6.3 | GO:0061042 | vascular wound healing(GO:0061042) |
2.1 | 10.5 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
2.1 | 2.1 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
2.1 | 6.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
2.1 | 14.4 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
2.0 | 4.1 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
2.0 | 4.1 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
2.0 | 8.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
2.0 | 38.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
2.0 | 4.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
2.0 | 8.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
2.0 | 2.0 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
2.0 | 4.0 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
2.0 | 6.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
2.0 | 4.0 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
2.0 | 8.0 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
2.0 | 4.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
2.0 | 10.0 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
2.0 | 16.0 | GO:0036065 | fucosylation(GO:0036065) |
2.0 | 2.0 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
2.0 | 2.0 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
2.0 | 33.7 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
2.0 | 5.9 | GO:0045475 | locomotor rhythm(GO:0045475) |
2.0 | 3.9 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
2.0 | 5.9 | GO:0031296 | B cell costimulation(GO:0031296) |
2.0 | 9.8 | GO:2000035 | regulation of stem cell division(GO:2000035) |
1.9 | 3.9 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.9 | 3.9 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
1.9 | 1.9 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
1.9 | 1.9 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
1.9 | 15.5 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
1.9 | 3.9 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
1.9 | 5.8 | GO:0002158 | osteoclast proliferation(GO:0002158) |
1.9 | 3.9 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
1.9 | 3.9 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
1.9 | 11.6 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
1.9 | 7.6 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.9 | 3.8 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
1.9 | 5.7 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
1.9 | 11.4 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
1.9 | 1.9 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
1.9 | 24.5 | GO:0045214 | sarcomere organization(GO:0045214) |
1.9 | 7.5 | GO:0060736 | prostate gland growth(GO:0060736) |
1.9 | 5.7 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
1.9 | 13.2 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
1.9 | 35.7 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
1.9 | 1.9 | GO:0030432 | peristalsis(GO:0030432) |
1.9 | 7.5 | GO:0007296 | vitellogenesis(GO:0007296) |
1.9 | 29.8 | GO:0007616 | long-term memory(GO:0007616) |
1.9 | 3.7 | GO:0042048 | olfactory behavior(GO:0042048) |
1.9 | 24.1 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
1.9 | 7.4 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
1.9 | 3.7 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
1.8 | 88.7 | GO:0001578 | microtubule bundle formation(GO:0001578) |
1.8 | 7.3 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
1.8 | 1.8 | GO:0003011 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
1.8 | 5.5 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
1.8 | 1.8 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.8 | 1.8 | GO:0048664 | neuron fate determination(GO:0048664) |
1.8 | 9.1 | GO:0046836 | glycolipid transport(GO:0046836) |
1.8 | 10.9 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
1.8 | 3.6 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
1.8 | 30.7 | GO:0007528 | neuromuscular junction development(GO:0007528) |
1.8 | 3.6 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
1.8 | 7.2 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
1.8 | 3.6 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
1.8 | 5.4 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
1.8 | 5.4 | GO:0015747 | urate transport(GO:0015747) |
1.8 | 8.9 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.8 | 3.6 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
1.8 | 1.8 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.8 | 3.6 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
1.8 | 7.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
1.8 | 5.3 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
1.8 | 5.3 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
1.8 | 1.8 | GO:0021747 | cochlear nucleus development(GO:0021747) |
1.8 | 5.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.8 | 5.3 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
1.7 | 7.0 | GO:0048318 | axial mesoderm development(GO:0048318) |
1.7 | 5.2 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
1.7 | 1.7 | GO:0061743 | motor learning(GO:0061743) |
1.7 | 3.4 | GO:0071731 | response to nitric oxide(GO:0071731) |
1.7 | 3.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.7 | 3.4 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
1.7 | 5.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
1.7 | 5.1 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
1.7 | 3.4 | GO:0070673 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
1.7 | 11.8 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
1.7 | 11.8 | GO:0033622 | integrin activation(GO:0033622) |
1.7 | 5.0 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
1.7 | 8.4 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
1.7 | 5.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.7 | 1.7 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
1.6 | 1.6 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
1.6 | 6.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
1.6 | 3.3 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
1.6 | 3.3 | GO:0070253 | somatostatin secretion(GO:0070253) |
1.6 | 4.9 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
1.6 | 19.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
1.6 | 4.8 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
1.6 | 3.2 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
1.6 | 16.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
1.6 | 17.7 | GO:0014850 | response to muscle activity(GO:0014850) |
1.6 | 3.2 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
1.6 | 1.6 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
1.6 | 4.8 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.6 | 9.6 | GO:0016322 | neuron remodeling(GO:0016322) |
1.6 | 1.6 | GO:0060157 | urinary bladder development(GO:0060157) |
1.6 | 20.8 | GO:0061462 | protein localization to lysosome(GO:0061462) |
1.6 | 1.6 | GO:0015755 | fructose transport(GO:0015755) |
1.6 | 9.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
1.6 | 4.7 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.6 | 1.6 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
1.6 | 7.8 | GO:0018158 | protein oxidation(GO:0018158) |
1.6 | 7.8 | GO:0034331 | cell junction maintenance(GO:0034331) |
1.6 | 15.6 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
1.6 | 3.1 | GO:0030035 | microspike assembly(GO:0030035) |
1.5 | 6.2 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
1.5 | 4.6 | GO:0046909 | intermembrane transport(GO:0046909) |
1.5 | 4.6 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
1.5 | 10.7 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
1.5 | 1.5 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
1.5 | 3.0 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
1.5 | 16.6 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
1.5 | 4.5 | GO:0042891 | antibiotic transport(GO:0042891) |
1.5 | 1.5 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
1.5 | 4.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.5 | 4.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
1.5 | 1.5 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
1.5 | 7.5 | GO:0022615 | protein to membrane docking(GO:0022615) |
1.5 | 1.5 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
1.5 | 4.5 | GO:0036233 | glycine import(GO:0036233) synaptic transmission, glycinergic(GO:0060012) |
1.5 | 7.4 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
1.5 | 5.9 | GO:0007135 | meiosis II(GO:0007135) |
1.5 | 3.0 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
1.5 | 2.9 | GO:0001757 | somite specification(GO:0001757) |
1.5 | 4.4 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.5 | 1.5 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
1.5 | 1.5 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
1.5 | 1.5 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
1.4 | 10.1 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
1.4 | 4.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.4 | 1.4 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
1.4 | 1.4 | GO:0045606 | positive regulation of epidermal cell differentiation(GO:0045606) |
1.4 | 5.7 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
1.4 | 2.9 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.4 | 7.1 | GO:0043584 | nose development(GO:0043584) |
1.4 | 27.1 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
1.4 | 1.4 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
1.4 | 1.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.4 | 8.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
1.4 | 1.4 | GO:0071288 | cellular response to copper ion(GO:0071280) cellular response to mercury ion(GO:0071288) |
1.4 | 2.8 | GO:0006983 | ER overload response(GO:0006983) |
1.4 | 1.4 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
1.4 | 2.8 | GO:0015888 | thiamine transport(GO:0015888) |
1.4 | 36.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
1.4 | 4.2 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
1.4 | 2.8 | GO:0036315 | cellular response to sterol(GO:0036315) |
1.4 | 7.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
1.4 | 1.4 | GO:0007494 | midgut development(GO:0007494) |
1.4 | 4.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
1.4 | 9.6 | GO:0060347 | heart trabecula formation(GO:0060347) |
1.4 | 2.7 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
1.4 | 2.7 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.4 | 6.8 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.4 | 5.5 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
1.4 | 4.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.4 | 1.4 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
1.4 | 1.4 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
1.4 | 4.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
1.4 | 9.5 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
1.3 | 6.7 | GO:0019228 | neuronal action potential(GO:0019228) |
1.3 | 4.0 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
1.3 | 6.6 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
1.3 | 7.9 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
1.3 | 2.6 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
1.3 | 2.6 | GO:0042940 | D-amino acid transport(GO:0042940) |
1.3 | 4.0 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
1.3 | 22.4 | GO:0006813 | potassium ion transport(GO:0006813) |
1.3 | 31.7 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
1.3 | 1.3 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
1.3 | 13.2 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
1.3 | 10.5 | GO:0044458 | motile cilium assembly(GO:0044458) |
1.3 | 5.3 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
1.3 | 14.5 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
1.3 | 6.6 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
1.3 | 2.6 | GO:0000255 | allantoin metabolic process(GO:0000255) |
1.3 | 2.6 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
1.3 | 2.6 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
1.3 | 2.6 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
1.3 | 2.6 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
1.3 | 3.9 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.3 | 1.3 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
1.3 | 9.0 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
1.3 | 5.2 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
1.3 | 3.9 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
1.3 | 2.6 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
1.3 | 2.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.3 | 2.5 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
1.3 | 3.8 | GO:0000733 | DNA strand renaturation(GO:0000733) |
1.3 | 2.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
1.3 | 2.5 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
1.3 | 2.5 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
1.3 | 2.5 | GO:0060005 | vestibular reflex(GO:0060005) |
1.2 | 3.7 | GO:0060056 | mammary gland involution(GO:0060056) |
1.2 | 33.7 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
1.2 | 8.7 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
1.2 | 7.5 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
1.2 | 1.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
1.2 | 4.9 | GO:0034650 | cortisol metabolic process(GO:0034650) |
1.2 | 9.8 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
1.2 | 1.2 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
1.2 | 3.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
1.2 | 3.7 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
1.2 | 1.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
1.2 | 3.6 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
1.2 | 3.6 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
1.2 | 7.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
1.2 | 14.3 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
1.2 | 8.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
1.2 | 1.2 | GO:0071316 | cellular response to nicotine(GO:0071316) |
1.2 | 9.4 | GO:0046548 | retinal rod cell development(GO:0046548) |
1.2 | 3.5 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
1.2 | 3.5 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
1.2 | 3.5 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
1.2 | 9.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
1.2 | 2.3 | GO:0006562 | proline catabolic process(GO:0006562) |
1.2 | 9.3 | GO:0045056 | transcytosis(GO:0045056) |
1.2 | 21.9 | GO:0007632 | visual behavior(GO:0007632) |
1.1 | 8.0 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
1.1 | 6.8 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
1.1 | 3.4 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
1.1 | 12.5 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
1.1 | 7.9 | GO:0010842 | retina layer formation(GO:0010842) |
1.1 | 1.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
1.1 | 4.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.1 | 2.2 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.1 | 1.1 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
1.1 | 2.2 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
1.1 | 2.2 | GO:0035973 | aggrephagy(GO:0035973) |
1.1 | 3.3 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
1.1 | 1.1 | GO:0034698 | response to gonadotropin(GO:0034698) |
1.1 | 1.1 | GO:0090192 | regulation of glomerulus development(GO:0090192) |
1.1 | 5.5 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
1.1 | 28.5 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
1.1 | 8.6 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
1.1 | 3.2 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
1.1 | 1.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
1.1 | 2.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
1.1 | 3.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.1 | 9.5 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
1.1 | 1.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
1.1 | 7.4 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
1.1 | 4.2 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
1.0 | 18.9 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
1.0 | 3.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
1.0 | 3.1 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
1.0 | 1.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
1.0 | 4.2 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
1.0 | 3.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
1.0 | 2.1 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
1.0 | 2.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
1.0 | 7.3 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
1.0 | 6.2 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
1.0 | 10.3 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
1.0 | 4.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
1.0 | 1.0 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
1.0 | 6.1 | GO:0002035 | regulation of blood volume by renin-angiotensin(GO:0002016) brain renin-angiotensin system(GO:0002035) |
1.0 | 11.2 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
1.0 | 3.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
1.0 | 9.1 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
1.0 | 4.0 | GO:0043129 | surfactant homeostasis(GO:0043129) |
1.0 | 9.0 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
1.0 | 3.0 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
1.0 | 13.9 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
1.0 | 1.0 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
1.0 | 3.0 | GO:0046541 | saliva secretion(GO:0046541) |
1.0 | 5.0 | GO:0036035 | osteoclast development(GO:0036035) |
1.0 | 5.9 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
1.0 | 3.9 | GO:0016584 | nucleosome positioning(GO:0016584) |
1.0 | 1.0 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
1.0 | 2.0 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
1.0 | 6.8 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
1.0 | 3.9 | GO:0015808 | L-alanine transport(GO:0015808) |
1.0 | 2.9 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
1.0 | 1.0 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
1.0 | 1.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.9 | 3.8 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.9 | 5.7 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.9 | 3.8 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.9 | 2.8 | GO:0006901 | vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.9 | 0.9 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.9 | 10.3 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.9 | 6.5 | GO:0006108 | malate metabolic process(GO:0006108) |
0.9 | 2.8 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.9 | 0.9 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.9 | 9.2 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.9 | 3.7 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.9 | 0.9 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.9 | 1.8 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.9 | 22.8 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.9 | 3.6 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.9 | 3.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.9 | 1.8 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.9 | 3.6 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.9 | 18.5 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.9 | 40.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.9 | 0.9 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.9 | 0.9 | GO:0070662 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.9 | 7.0 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.9 | 6.1 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.9 | 6.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.9 | 0.9 | GO:0060290 | transdifferentiation(GO:0060290) |
0.9 | 0.9 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.9 | 3.5 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.9 | 6.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.9 | 7.7 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.9 | 5.1 | GO:0006900 | membrane budding(GO:0006900) |
0.8 | 2.5 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.8 | 4.2 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.8 | 2.5 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.8 | 2.5 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.8 | 3.4 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.8 | 0.8 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.8 | 1.7 | GO:0035640 | exploration behavior(GO:0035640) |
0.8 | 3.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.8 | 3.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.8 | 4.1 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.8 | 4.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.8 | 7.4 | GO:0030575 | nuclear body organization(GO:0030575) |
0.8 | 4.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.8 | 9.8 | GO:0097576 | vacuole fusion(GO:0097576) |
0.8 | 10.5 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.8 | 5.5 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) |
0.8 | 4.7 | GO:0007340 | acrosome reaction(GO:0007340) |
0.8 | 7.0 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.8 | 1.5 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.8 | 5.4 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.8 | 5.4 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.8 | 7.6 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.8 | 0.8 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.8 | 1.5 | GO:0070268 | cornification(GO:0070268) |
0.8 | 2.3 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.8 | 3.8 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.7 | 3.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.7 | 0.7 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.7 | 21.4 | GO:0015914 | phospholipid transport(GO:0015914) |
0.7 | 2.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.7 | 0.7 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.7 | 2.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.7 | 27.4 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.7 | 2.2 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.7 | 5.0 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.7 | 1.4 | GO:0007320 | insemination(GO:0007320) |
0.7 | 2.1 | GO:0001895 | retina homeostasis(GO:0001895) |
0.7 | 2.1 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.7 | 0.7 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.7 | 8.3 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.7 | 3.5 | GO:0007000 | nucleolus organization(GO:0007000) |
0.7 | 0.7 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.7 | 5.5 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.7 | 3.4 | GO:0021766 | hippocampus development(GO:0021766) |
0.7 | 2.7 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.7 | 2.0 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.7 | 0.7 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.7 | 2.0 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.7 | 38.6 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.7 | 2.0 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.7 | 4.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.7 | 3.3 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.6 | 1.3 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.6 | 1.9 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.6 | 1.3 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.6 | 7.0 | GO:0032400 | melanosome localization(GO:0032400) |
0.6 | 2.5 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.6 | 2.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.6 | 1.3 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.6 | 1.3 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.6 | 2.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.6 | 3.8 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.6 | 2.5 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.6 | 0.6 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.6 | 1.8 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.6 | 9.2 | GO:0097186 | amelogenesis(GO:0097186) |
0.6 | 3.6 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.6 | 0.6 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.6 | 0.6 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.6 | 1.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.6 | 1.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.6 | 1.1 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.6 | 2.8 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.6 | 2.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.6 | 0.6 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.6 | 1.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.5 | 1.6 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.5 | 1.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.5 | 2.2 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.5 | 14.1 | GO:0031424 | keratinization(GO:0031424) |
0.5 | 0.5 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.5 | 1.6 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.5 | 0.5 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.5 | 1.1 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.5 | 13.9 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.5 | 1.6 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.5 | 0.5 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.5 | 2.1 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.5 | 9.4 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.5 | 0.5 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.5 | 3.6 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.5 | 9.7 | GO:0034605 | cellular response to heat(GO:0034605) |
0.5 | 0.5 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) pilomotor reflex(GO:0097195) |
0.5 | 1.0 | GO:0060384 | innervation(GO:0060384) |
0.5 | 1.0 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.5 | 2.5 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.5 | 1.0 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.5 | 0.5 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.5 | 6.9 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.5 | 1.5 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.5 | 0.5 | GO:0072044 | collecting duct development(GO:0072044) |
0.5 | 3.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.5 | 4.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.5 | 1.4 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.5 | 4.5 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.5 | 0.9 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.4 | 0.4 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.4 | 0.4 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.4 | 2.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.4 | 1.3 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.4 | 2.6 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.4 | 0.4 | GO:0032570 | response to progesterone(GO:0032570) |
0.4 | 0.9 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.4 | 0.9 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.4 | 0.4 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.4 | 9.4 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.4 | 6.3 | GO:0050808 | synapse organization(GO:0050808) |
0.4 | 0.4 | GO:0090383 | phagosome acidification(GO:0090383) |
0.4 | 3.7 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.4 | 0.4 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.4 | 0.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.4 | 0.8 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.4 | 1.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.4 | 1.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.4 | 1.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.4 | 0.8 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.4 | 1.6 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.4 | 3.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.4 | 2.4 | GO:0008347 | glial cell migration(GO:0008347) |
0.4 | 0.4 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.4 | 0.4 | GO:0086001 | cardiac muscle cell action potential(GO:0086001) |
0.4 | 0.4 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.4 | 0.8 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.4 | 1.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.4 | 11.4 | GO:0007566 | embryo implantation(GO:0007566) |
0.4 | 0.7 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.4 | 3.2 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.4 | 0.4 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.4 | 0.7 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 5.9 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.3 | 1.7 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.3 | 0.3 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.3 | 7.8 | GO:0050905 | neuromuscular process(GO:0050905) |
0.3 | 0.3 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.3 | 1.0 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.3 | 1.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.3 | 5.5 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.3 | 3.9 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.3 | 1.0 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.3 | 3.2 | GO:0048240 | sperm capacitation(GO:0048240) |
0.3 | 0.3 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.3 | 0.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.3 | 3.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 1.7 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.3 | 0.6 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.3 | 3.1 | GO:0035329 | hippo signaling(GO:0035329) |
0.3 | 0.3 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.3 | 1.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.3 | 4.4 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.3 | 0.3 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.3 | 0.5 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.3 | 0.3 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) |
0.3 | 0.5 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.3 | 0.3 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.3 | 0.3 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.3 | 0.8 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 1.0 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.2 | 0.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.2 | 0.2 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.2 | 2.3 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.2 | 0.7 | GO:0038084 | vascular endothelial growth factor signaling pathway(GO:0038084) |
0.2 | 1.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 0.9 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.2 | 0.7 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 0.4 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.2 | 2.0 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.2 | 0.2 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.2 | 4.4 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
0.2 | 1.5 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 0.4 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.6 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.2 | 0.2 | GO:1902307 | sodium ion export(GO:0071436) positive regulation of sodium ion transmembrane transport(GO:1902307) |
0.2 | 0.4 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 1.1 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.2 | 0.2 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.2 | 0.2 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.2 | 0.9 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.3 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
0.2 | 1.5 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 0.3 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 0.2 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.2 | 1.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.2 | 0.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 0.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 0.5 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.2 | 0.3 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.2 | 0.9 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.9 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.9 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.4 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 0.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 0.6 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.2 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.2 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.1 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 0.2 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 2.2 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 5.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.9 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 0.1 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.1 | 1.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.2 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 1.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 1.0 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.4 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.1 | 0.9 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.2 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.1 | 0.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.2 | GO:2000341 | chemokine (C-X-C motif) ligand 2 production(GO:0072567) regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
0.1 | 0.2 | GO:1904504 | lipophagy(GO:0061724) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.1 | 0.2 | GO:0015824 | proline transport(GO:0015824) |
0.1 | 0.2 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.1 | 0.1 | GO:0071863 | regulation of cell proliferation in bone marrow(GO:0071863) |
0.1 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 1.5 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.1 | 2.3 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 0.1 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.1 | 0.1 | GO:0061308 | cardiac neural crest cell development involved in heart development(GO:0061308) |
0.1 | 0.3 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.1 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.4 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.1 | GO:0071675 | regulation of mononuclear cell migration(GO:0071675) |
0.1 | 0.4 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.0 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.0 | 0.0 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.0 | 0.3 | GO:0007595 | lactation(GO:0007595) |
0.0 | 0.1 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.1 | GO:0050862 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.0 | GO:1903960 | negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
0.0 | 0.2 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.0 | 0.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.5 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.0 | 0.3 | GO:0042551 | neuron maturation(GO:0042551) |
0.0 | 0.1 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.0 | 0.4 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.1 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.0 | 0.0 | GO:0001999 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) |
0.0 | 0.0 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.0 | 0.0 | GO:0032621 | interleukin-18 production(GO:0032621) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.0 | 134.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
14.2 | 99.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
12.7 | 76.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
11.3 | 34.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
10.1 | 20.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
9.6 | 28.9 | GO:1990812 | growth cone filopodium(GO:1990812) |
9.3 | 9.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
9.1 | 153.9 | GO:0005614 | interstitial matrix(GO:0005614) |
8.9 | 53.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
8.7 | 52.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
8.7 | 26.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
8.3 | 24.8 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
8.2 | 24.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
8.0 | 24.0 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
7.9 | 23.8 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
7.9 | 23.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
7.8 | 31.4 | GO:0071953 | elastic fiber(GO:0071953) |
7.8 | 70.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
7.8 | 23.4 | GO:0072534 | perineuronal net(GO:0072534) |
7.6 | 68.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
6.9 | 27.8 | GO:0044308 | axonal spine(GO:0044308) |
6.8 | 6.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
6.2 | 25.0 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
6.1 | 30.4 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
5.9 | 35.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
5.9 | 29.4 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
5.8 | 52.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
5.8 | 29.1 | GO:0033268 | node of Ranvier(GO:0033268) |
5.7 | 34.4 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
5.7 | 39.9 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
5.7 | 73.5 | GO:0005916 | fascia adherens(GO:0005916) |
5.5 | 16.6 | GO:1990357 | terminal web(GO:1990357) |
5.5 | 65.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
5.4 | 21.7 | GO:0030478 | actin cap(GO:0030478) |
5.4 | 86.5 | GO:0030673 | axolemma(GO:0030673) |
5.4 | 59.3 | GO:0043194 | axon initial segment(GO:0043194) |
5.4 | 96.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
5.2 | 52.2 | GO:0001527 | microfibril(GO:0001527) |
5.2 | 31.3 | GO:0005915 | zonula adherens(GO:0005915) |
5.1 | 40.4 | GO:0005861 | troponin complex(GO:0005861) |
5.0 | 55.2 | GO:0031527 | filopodium membrane(GO:0031527) |
4.9 | 58.9 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
4.9 | 14.7 | GO:0043511 | inhibin complex(GO:0043511) |
4.9 | 14.7 | GO:0097513 | myosin II filament(GO:0097513) |
4.9 | 282.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
4.7 | 37.9 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
4.7 | 18.7 | GO:0016342 | catenin complex(GO:0016342) |
4.7 | 14.0 | GO:0097427 | microtubule bundle(GO:0097427) |
4.6 | 4.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
4.6 | 13.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
4.6 | 138.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
4.6 | 13.9 | GO:0044299 | C-fiber(GO:0044299) |
4.6 | 27.7 | GO:0043083 | synaptic cleft(GO:0043083) |
4.6 | 13.7 | GO:0032279 | asymmetric synapse(GO:0032279) |
4.5 | 45.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
4.4 | 30.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
4.3 | 13.0 | GO:0043293 | apoptosome(GO:0043293) |
4.3 | 17.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
4.2 | 42.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
4.1 | 16.3 | GO:0097433 | dense body(GO:0097433) |
4.0 | 580.5 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
4.0 | 63.4 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
3.9 | 11.7 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
3.9 | 11.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
3.9 | 11.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
3.8 | 15.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
3.8 | 30.4 | GO:0001520 | outer dense fiber(GO:0001520) |
3.8 | 34.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
3.8 | 11.3 | GO:0048179 | activin receptor complex(GO:0048179) |
3.7 | 33.7 | GO:0005605 | basal lamina(GO:0005605) |
3.7 | 3.7 | GO:0035838 | growing cell tip(GO:0035838) |
3.7 | 51.9 | GO:0060076 | excitatory synapse(GO:0060076) |
3.7 | 3.7 | GO:0044393 | microspike(GO:0044393) |
3.6 | 68.7 | GO:0044295 | axonal growth cone(GO:0044295) |
3.6 | 14.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
3.6 | 46.3 | GO:0097440 | apical dendrite(GO:0097440) |
3.5 | 10.4 | GO:1990393 | 3M complex(GO:1990393) |
3.4 | 3.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
3.3 | 16.3 | GO:0005883 | neurofilament(GO:0005883) |
3.2 | 126.2 | GO:0034704 | calcium channel complex(GO:0034704) |
3.2 | 3.2 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
3.2 | 9.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
3.1 | 12.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
3.1 | 18.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
3.0 | 21.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
2.9 | 8.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
2.9 | 37.7 | GO:0070382 | exocytic vesicle(GO:0070382) |
2.9 | 20.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
2.9 | 8.7 | GO:0045180 | basal cortex(GO:0045180) |
2.8 | 11.3 | GO:0070545 | PeBoW complex(GO:0070545) |
2.8 | 22.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
2.8 | 56.1 | GO:0043198 | dendritic shaft(GO:0043198) |
2.8 | 8.3 | GO:0042583 | chromaffin granule(GO:0042583) |
2.7 | 33.0 | GO:0071564 | npBAF complex(GO:0071564) |
2.7 | 81.2 | GO:0005581 | collagen trimer(GO:0005581) |
2.7 | 8.0 | GO:0034706 | sodium channel complex(GO:0034706) |
2.6 | 2.6 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
2.5 | 225.8 | GO:0045211 | postsynaptic membrane(GO:0045211) |
2.5 | 7.5 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
2.5 | 9.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
2.5 | 19.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
2.4 | 7.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
2.4 | 7.2 | GO:0000322 | storage vacuole(GO:0000322) |
2.4 | 9.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
2.3 | 6.9 | GO:0043203 | axon hillock(GO:0043203) |
2.3 | 2.3 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
2.2 | 4.5 | GO:0030427 | site of polarized growth(GO:0030427) |
2.2 | 11.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
2.2 | 70.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
2.2 | 6.6 | GO:0032585 | multivesicular body membrane(GO:0032585) |
2.2 | 89.7 | GO:0016459 | myosin complex(GO:0016459) |
2.2 | 17.4 | GO:0036157 | outer dynein arm(GO:0036157) |
2.2 | 32.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
2.1 | 4.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
2.1 | 55.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
2.1 | 4.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
2.1 | 10.5 | GO:0032433 | filopodium tip(GO:0032433) |
2.1 | 8.4 | GO:0033263 | CORVET complex(GO:0033263) |
2.0 | 506.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
2.0 | 56.9 | GO:0005921 | gap junction(GO:0005921) |
2.0 | 24.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
2.0 | 13.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
2.0 | 11.8 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
1.9 | 11.6 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
1.9 | 3.9 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.9 | 5.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.9 | 5.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.9 | 16.8 | GO:0044298 | cell body membrane(GO:0044298) |
1.9 | 28.0 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) AMPA glutamate receptor complex(GO:0032281) neurotransmitter receptor complex(GO:0098878) |
1.8 | 5.5 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
1.8 | 12.7 | GO:0042587 | glycogen granule(GO:0042587) |
1.8 | 30.8 | GO:0030057 | desmosome(GO:0030057) |
1.8 | 3.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.8 | 5.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.8 | 24.6 | GO:0005865 | striated muscle thin filament(GO:0005865) |
1.8 | 483.0 | GO:0045202 | synapse(GO:0045202) |
1.8 | 1.8 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
1.7 | 10.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.7 | 1.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.7 | 20.7 | GO:0046930 | pore complex(GO:0046930) |
1.7 | 15.5 | GO:0097542 | ciliary tip(GO:0097542) |
1.7 | 10.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
1.7 | 8.6 | GO:0031430 | M band(GO:0031430) |
1.7 | 8.5 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
1.7 | 11.7 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
1.6 | 4.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
1.6 | 20.6 | GO:0044291 | cell-cell contact zone(GO:0044291) |
1.6 | 11.0 | GO:0043034 | costamere(GO:0043034) |
1.6 | 4.7 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
1.6 | 11.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
1.5 | 4.6 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
1.5 | 12.3 | GO:0031143 | pseudopodium(GO:0031143) |
1.5 | 7.6 | GO:0070695 | FHF complex(GO:0070695) |
1.5 | 10.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.5 | 103.5 | GO:0030027 | lamellipodium(GO:0030027) |
1.5 | 69.4 | GO:0005884 | actin filament(GO:0005884) |
1.4 | 62.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
1.4 | 7.1 | GO:0071547 | piP-body(GO:0071547) |
1.4 | 170.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
1.4 | 4.2 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.3 | 1.3 | GO:1990696 | USH2 complex(GO:1990696) |
1.3 | 75.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
1.3 | 11.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.3 | 43.3 | GO:0005871 | kinesin complex(GO:0005871) |
1.3 | 13.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.3 | 7.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.2 | 4.9 | GO:1990716 | axonemal central apparatus(GO:1990716) |
1.2 | 19.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
1.2 | 16.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
1.2 | 22.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
1.2 | 13.8 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
1.1 | 4.5 | GO:0097209 | epidermal lamellar body(GO:0097209) |
1.1 | 1.1 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
1.1 | 2.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.1 | 6.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.1 | 9.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
1.1 | 2.1 | GO:1990635 | proximal dendrite(GO:1990635) |
1.1 | 3.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
1.0 | 12.5 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
1.0 | 2.0 | GO:0042585 | germinal vesicle(GO:0042585) |
1.0 | 4.9 | GO:0033503 | HULC complex(GO:0033503) |
1.0 | 2.9 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
1.0 | 8.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.0 | 2.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.0 | 29.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
1.0 | 4.8 | GO:0044292 | dendrite terminus(GO:0044292) |
1.0 | 1.9 | GO:0070820 | tertiary granule(GO:0070820) |
0.9 | 8.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.9 | 4.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.9 | 24.9 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.9 | 6.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.9 | 2.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.9 | 14.5 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.9 | 2.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.9 | 1.8 | GO:0071942 | XPC complex(GO:0071942) |
0.9 | 10.4 | GO:0044447 | axoneme part(GO:0044447) |
0.8 | 10.8 | GO:0000800 | lateral element(GO:0000800) |
0.8 | 1.6 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.8 | 8.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.8 | 2.4 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.8 | 6.2 | GO:0002102 | podosome(GO:0002102) |
0.8 | 4.6 | GO:0032590 | dendrite membrane(GO:0032590) |
0.8 | 37.9 | GO:0031012 | extracellular matrix(GO:0031012) |
0.8 | 7.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.7 | 4.5 | GO:0097342 | ripoptosome(GO:0097342) |
0.7 | 53.7 | GO:0043296 | apical junction complex(GO:0043296) |
0.7 | 2.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.7 | 2.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.7 | 12.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.7 | 4.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.7 | 10.4 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.7 | 2.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.7 | 13.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.7 | 14.9 | GO:0016235 | aggresome(GO:0016235) |
0.7 | 18.7 | GO:0072686 | mitotic spindle(GO:0072686) |
0.7 | 2.0 | GO:0044194 | cytolytic granule(GO:0044194) |
0.7 | 35.9 | GO:0043025 | neuronal cell body(GO:0043025) |
0.6 | 14.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.6 | 4.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.6 | 38.2 | GO:0030016 | myofibril(GO:0030016) |
0.6 | 11.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.6 | 1.8 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.6 | 2.9 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.6 | 22.6 | GO:0043204 | perikaryon(GO:0043204) |
0.6 | 41.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.5 | 3.1 | GO:0070847 | core mediator complex(GO:0070847) |
0.5 | 3.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.5 | 4.6 | GO:0033391 | chromatoid body(GO:0033391) |
0.5 | 2.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.5 | 4.0 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.5 | 4.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.5 | 5.7 | GO:0036038 | MKS complex(GO:0036038) |
0.5 | 1.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.5 | 0.5 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.5 | 11.6 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.5 | 14.7 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.4 | 4.0 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.4 | 1.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.4 | 3.5 | GO:0030315 | T-tubule(GO:0030315) |
0.4 | 128.6 | GO:0043005 | neuron projection(GO:0043005) |
0.4 | 1.2 | GO:0031417 | NatC complex(GO:0031417) |
0.4 | 41.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.4 | 6.6 | GO:0032420 | stereocilium(GO:0032420) |
0.4 | 1.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 26.5 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.3 | 0.6 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.3 | 2.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.3 | 1.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.3 | 2.9 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.3 | 0.6 | GO:0072687 | meiotic spindle(GO:0072687) |
0.3 | 1.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 0.8 | GO:0071203 | WASH complex(GO:0071203) |
0.3 | 0.8 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.3 | 41.5 | GO:0005912 | adherens junction(GO:0005912) |
0.2 | 1.0 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 0.2 | GO:0034705 | potassium channel complex(GO:0034705) |
0.2 | 0.4 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 20.3 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.2 | 0.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 1.3 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.2 | 0.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 1.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 0.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.2 | 1.7 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 1.0 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 6.3 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.0 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.0 | 1.0 | GO:0001533 | cornified envelope(GO:0001533) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
21.8 | 65.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
19.1 | 19.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
16.5 | 49.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
16.4 | 49.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
16.2 | 64.8 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
15.7 | 47.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
14.5 | 14.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
14.1 | 56.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
13.6 | 40.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
13.1 | 26.2 | GO:0030172 | troponin C binding(GO:0030172) |
13.1 | 52.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
13.1 | 104.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
12.3 | 36.9 | GO:0045503 | dynein light chain binding(GO:0045503) |
11.6 | 23.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
11.6 | 58.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
11.1 | 33.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
10.9 | 43.7 | GO:0038064 | collagen receptor activity(GO:0038064) |
10.7 | 21.4 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
10.5 | 52.5 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
10.3 | 20.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
10.1 | 50.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
9.9 | 9.9 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
9.9 | 39.5 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
9.8 | 29.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
9.6 | 28.7 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
9.4 | 56.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
9.0 | 27.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
8.9 | 35.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
8.9 | 26.7 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
8.9 | 26.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
8.7 | 34.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
8.5 | 68.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
8.5 | 8.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
8.3 | 41.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
8.3 | 33.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
8.0 | 16.1 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
8.0 | 31.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
7.9 | 39.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
7.7 | 23.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
7.5 | 22.4 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
7.0 | 21.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
6.8 | 54.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
6.8 | 20.3 | GO:0051373 | FATZ binding(GO:0051373) |
6.8 | 27.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
6.7 | 33.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
6.6 | 6.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
6.5 | 13.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
6.4 | 32.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
6.3 | 69.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
6.2 | 31.0 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
6.2 | 30.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
6.1 | 55.3 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
6.0 | 24.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
5.9 | 11.8 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
5.9 | 17.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
5.8 | 17.3 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
5.7 | 28.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
5.7 | 11.4 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
5.7 | 11.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
5.5 | 27.7 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
5.5 | 11.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
5.5 | 227.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
5.5 | 16.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
5.5 | 164.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
5.4 | 21.6 | GO:0070052 | collagen V binding(GO:0070052) |
5.2 | 10.5 | GO:0051425 | PTB domain binding(GO:0051425) |
5.2 | 67.8 | GO:0031005 | filamin binding(GO:0031005) |
5.2 | 26.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
5.2 | 46.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
5.1 | 71.6 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
5.1 | 76.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
5.1 | 20.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
5.0 | 15.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
5.0 | 20.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
5.0 | 14.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
4.9 | 29.6 | GO:0031432 | titin binding(GO:0031432) |
4.9 | 9.8 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
4.9 | 53.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
4.9 | 19.4 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
4.8 | 62.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
4.8 | 9.7 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
4.7 | 23.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
4.7 | 14.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
4.6 | 13.9 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
4.6 | 18.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
4.6 | 13.7 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
4.6 | 36.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
4.6 | 59.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
4.5 | 136.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
4.5 | 4.5 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
4.4 | 39.6 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
4.4 | 13.2 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
4.4 | 8.8 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
4.4 | 8.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
4.4 | 4.4 | GO:0031705 | bombesin receptor binding(GO:0031705) |
4.4 | 143.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
4.3 | 17.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
4.3 | 25.8 | GO:0048495 | Roundabout binding(GO:0048495) |
4.2 | 21.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
4.2 | 12.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
4.1 | 12.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
4.1 | 74.4 | GO:0003785 | actin monomer binding(GO:0003785) |
4.1 | 16.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
4.1 | 20.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
4.0 | 36.2 | GO:0038191 | neuropilin binding(GO:0038191) |
4.0 | 44.1 | GO:0005522 | profilin binding(GO:0005522) |
4.0 | 15.9 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
4.0 | 15.9 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
4.0 | 15.8 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
4.0 | 7.9 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
3.9 | 15.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
3.9 | 15.7 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
3.9 | 164.4 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
3.9 | 15.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
3.9 | 120.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
3.9 | 11.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
3.9 | 57.9 | GO:0030553 | cGMP binding(GO:0030553) |
3.8 | 30.8 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
3.8 | 11.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
3.8 | 11.5 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
3.8 | 19.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
3.8 | 18.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
3.8 | 22.6 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
3.7 | 37.5 | GO:0051378 | serotonin binding(GO:0051378) |
3.7 | 48.4 | GO:0031402 | sodium ion binding(GO:0031402) |
3.7 | 18.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
3.7 | 11.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
3.7 | 25.6 | GO:0003680 | AT DNA binding(GO:0003680) |
3.6 | 43.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
3.6 | 43.3 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
3.6 | 10.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
3.6 | 10.7 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
3.5 | 241.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
3.5 | 63.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
3.5 | 31.7 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
3.5 | 7.0 | GO:0031013 | troponin I binding(GO:0031013) |
3.5 | 3.5 | GO:0017002 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
3.5 | 10.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
3.5 | 14.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
3.5 | 34.9 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
3.5 | 10.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
3.4 | 78.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
3.4 | 17.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
3.4 | 23.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
3.4 | 54.4 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
3.4 | 6.8 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
3.4 | 23.7 | GO:0018633 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
3.3 | 10.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
3.3 | 19.7 | GO:0034711 | inhibin binding(GO:0034711) |
3.3 | 32.8 | GO:0015026 | coreceptor activity(GO:0015026) |
3.3 | 26.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
3.3 | 94.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
3.2 | 168.5 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
3.2 | 6.4 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
3.2 | 22.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
3.2 | 6.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
3.2 | 67.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
3.2 | 12.8 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
3.1 | 6.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
3.1 | 9.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
3.1 | 53.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
3.1 | 28.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
3.1 | 37.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
3.1 | 37.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
3.1 | 9.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
3.1 | 15.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
3.0 | 6.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
3.0 | 30.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
3.0 | 9.0 | GO:0030284 | estrogen receptor activity(GO:0030284) |
3.0 | 44.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
3.0 | 8.9 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
3.0 | 8.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
2.9 | 2.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
2.9 | 20.6 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
2.9 | 5.9 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
2.9 | 8.8 | GO:0035939 | microsatellite binding(GO:0035939) |
2.9 | 8.7 | GO:0016015 | morphogen activity(GO:0016015) |
2.9 | 31.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
2.8 | 11.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
2.8 | 22.7 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
2.8 | 5.7 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
2.8 | 8.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
2.8 | 11.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
2.7 | 10.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
2.7 | 8.2 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
2.7 | 18.9 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
2.7 | 5.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
2.7 | 2.7 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) MAP kinase phosphatase activity(GO:0033549) |
2.7 | 8.1 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
2.7 | 21.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
2.7 | 2.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
2.7 | 10.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
2.6 | 7.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
2.6 | 5.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
2.5 | 61.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
2.5 | 43.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
2.5 | 5.1 | GO:0043199 | sulfate binding(GO:0043199) |
2.5 | 12.6 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
2.5 | 25.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
2.5 | 10.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
2.5 | 7.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
2.5 | 17.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
2.5 | 2.5 | GO:0048185 | activin binding(GO:0048185) |
2.5 | 29.7 | GO:0005272 | sodium channel activity(GO:0005272) |
2.5 | 22.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
2.5 | 7.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
2.4 | 7.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
2.4 | 48.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
2.4 | 68.0 | GO:0005267 | potassium channel activity(GO:0005267) |
2.4 | 7.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
2.4 | 7.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.4 | 12.0 | GO:0045545 | syndecan binding(GO:0045545) |
2.4 | 31.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
2.4 | 9.5 | GO:0070728 | leucine binding(GO:0070728) |
2.4 | 26.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
2.4 | 11.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
2.3 | 7.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
2.3 | 13.9 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
2.3 | 46.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
2.3 | 4.6 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
2.3 | 16.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
2.3 | 6.9 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
2.3 | 6.9 | GO:0061665 | SUMO ligase activity(GO:0061665) |
2.3 | 11.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
2.3 | 6.9 | GO:0055100 | adiponectin binding(GO:0055100) |
2.3 | 9.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
2.2 | 6.7 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
2.2 | 13.4 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
2.2 | 4.4 | GO:0030984 | kininogen binding(GO:0030984) |
2.2 | 39.8 | GO:0031489 | myosin V binding(GO:0031489) |
2.2 | 2.2 | GO:0050693 | LBD domain binding(GO:0050693) |
2.2 | 2.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
2.2 | 15.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
2.2 | 2.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
2.2 | 84.0 | GO:0005518 | collagen binding(GO:0005518) |
2.2 | 8.6 | GO:0046790 | virion binding(GO:0046790) |
2.2 | 2.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
2.1 | 6.4 | GO:0017166 | vinculin binding(GO:0017166) |
2.1 | 51.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
2.1 | 44.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
2.1 | 6.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
2.1 | 8.4 | GO:0030274 | LIM domain binding(GO:0030274) |
2.1 | 47.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
2.1 | 10.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
2.1 | 20.6 | GO:0042805 | actinin binding(GO:0042805) |
2.1 | 14.4 | GO:0050700 | CARD domain binding(GO:0050700) |
2.0 | 4.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
2.0 | 36.6 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
2.0 | 6.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
2.0 | 6.0 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
2.0 | 8.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
2.0 | 6.0 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
2.0 | 18.0 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
2.0 | 4.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
2.0 | 2.0 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
2.0 | 7.9 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
2.0 | 5.9 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
2.0 | 13.8 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
2.0 | 23.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
1.9 | 1.9 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.9 | 15.5 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
1.9 | 7.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
1.9 | 28.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
1.9 | 1.9 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.9 | 22.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
1.9 | 9.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.8 | 3.7 | GO:0071723 | lipopeptide binding(GO:0071723) |
1.8 | 3.7 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.8 | 1.8 | GO:0089720 | caspase binding(GO:0089720) |
1.8 | 7.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.8 | 1.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.8 | 12.8 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
1.8 | 19.9 | GO:0001223 | transcription coactivator binding(GO:0001223) |
1.8 | 39.9 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
1.8 | 5.4 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
1.8 | 7.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.8 | 1.8 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
1.8 | 14.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
1.8 | 212.0 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
1.8 | 3.5 | GO:0099528 | dopamine neurotransmitter receptor activity(GO:0004952) G-protein coupled neurotransmitter receptor activity(GO:0099528) |
1.7 | 12.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
1.7 | 22.3 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
1.7 | 23.9 | GO:0030552 | cAMP binding(GO:0030552) |
1.7 | 3.4 | GO:2001070 | starch binding(GO:2001070) |
1.7 | 11.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
1.7 | 3.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.7 | 8.3 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
1.7 | 1.7 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.6 | 4.9 | GO:0022834 | ligand-gated ion channel activity(GO:0015276) ligand-gated channel activity(GO:0022834) |
1.6 | 47.0 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
1.6 | 56.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
1.6 | 6.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
1.6 | 6.5 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.6 | 8.1 | GO:0052687 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
1.6 | 8.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.6 | 6.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
1.6 | 9.5 | GO:0008517 | folic acid transporter activity(GO:0008517) |
1.6 | 6.3 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
1.6 | 4.7 | GO:1904680 | peptide-transporting ATPase activity(GO:0015440) peptide transmembrane transporter activity(GO:1904680) |
1.6 | 6.3 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
1.6 | 32.8 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
1.6 | 424.0 | GO:0003779 | actin binding(GO:0003779) |
1.5 | 18.5 | GO:0017022 | myosin binding(GO:0017022) |
1.5 | 3.1 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
1.5 | 8.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.5 | 2.9 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
1.5 | 5.8 | GO:0043842 | Kdo transferase activity(GO:0043842) |
1.4 | 1.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.4 | 1.4 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
1.4 | 5.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
1.4 | 4.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
1.4 | 40.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
1.4 | 4.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
1.4 | 18.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
1.4 | 18.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
1.4 | 4.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.4 | 22.1 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
1.4 | 12.4 | GO:0017065 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
1.4 | 15.1 | GO:0043394 | proteoglycan binding(GO:0043394) |
1.4 | 6.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
1.4 | 2.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.3 | 33.7 | GO:0019894 | kinesin binding(GO:0019894) |
1.3 | 5.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.3 | 4.0 | GO:0019959 | interleukin-8 binding(GO:0019959) |
1.3 | 4.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
1.3 | 2.6 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
1.3 | 11.7 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
1.3 | 2.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.3 | 3.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.3 | 8.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.3 | 35.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
1.3 | 3.8 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
1.3 | 8.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.2 | 66.5 | GO:0005178 | integrin binding(GO:0005178) |
1.2 | 6.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
1.2 | 2.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.2 | 94.2 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
1.2 | 3.6 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
1.2 | 19.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.2 | 3.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
1.2 | 6.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.2 | 30.8 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
1.2 | 5.9 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
1.2 | 16.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
1.2 | 7.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.2 | 2.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
1.2 | 10.5 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
1.2 | 16.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
1.1 | 2.3 | GO:0051380 | norepinephrine binding(GO:0051380) |
1.1 | 3.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.1 | 4.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
1.1 | 6.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
1.1 | 7.9 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.1 | 3.3 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
1.1 | 11.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
1.1 | 14.2 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
1.1 | 4.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
1.1 | 5.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
1.1 | 11.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
1.1 | 19.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
1.0 | 12.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
1.0 | 1.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
1.0 | 4.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.0 | 4.1 | GO:0034584 | piRNA binding(GO:0034584) |
1.0 | 2.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.0 | 3.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
1.0 | 1.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
1.0 | 48.9 | GO:0005261 | cation channel activity(GO:0005261) |
1.0 | 21.7 | GO:0015485 | cholesterol binding(GO:0015485) |
1.0 | 4.9 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
1.0 | 5.8 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
1.0 | 40.0 | GO:0004394 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.9 | 8.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.9 | 6.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.9 | 188.3 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.9 | 3.6 | GO:0016936 | galactoside binding(GO:0016936) |
0.9 | 3.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.9 | 29.8 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.8 | 1.7 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.8 | 10.1 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.8 | 13.3 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.8 | 24.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.8 | 5.8 | GO:0005112 | Notch binding(GO:0005112) |
0.8 | 3.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.8 | 1.6 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.8 | 2.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.8 | 4.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.8 | 0.8 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.8 | 2.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.8 | 32.7 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.8 | 5.4 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.8 | 3.9 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.8 | 4.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.8 | 7.6 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.8 | 1.5 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.7 | 2.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.7 | 16.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.7 | 2.8 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.7 | 1.4 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.7 | 3.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.7 | 2.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.7 | 1.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.7 | 1.4 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.7 | 2.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.7 | 4.8 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.7 | 52.4 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.7 | 2.0 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.7 | 4.7 | GO:0000150 | recombinase activity(GO:0000150) |
0.7 | 2.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.7 | 10.1 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.7 | 4.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.7 | 3.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.7 | 8.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.7 | 18.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.6 | 0.6 | GO:0031433 | telethonin binding(GO:0031433) |
0.6 | 1.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.6 | 1.9 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.6 | 1.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.6 | 34.0 | GO:0008083 | growth factor activity(GO:0008083) |
0.6 | 8.6 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.6 | 50.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.6 | 12.2 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.6 | 1.8 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.6 | 4.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.6 | 1.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.6 | 4.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.6 | 11.2 | GO:0005537 | mannose binding(GO:0005537) |
0.6 | 0.6 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.6 | 1.7 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.6 | 1.7 | GO:0004802 | transketolase activity(GO:0004802) |
0.5 | 4.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.5 | 5.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.5 | 1.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.5 | 2.6 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.5 | 1.5 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.5 | 4.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.5 | 2.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.5 | 6.9 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.5 | 9.3 | GO:0070888 | E-box binding(GO:0070888) |
0.5 | 1.5 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.5 | 10.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.5 | 0.9 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.5 | 161.5 | GO:0005509 | calcium ion binding(GO:0005509) |
0.5 | 0.9 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.5 | 5.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.4 | 0.4 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.4 | 2.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.4 | 26.8 | GO:0005179 | hormone activity(GO:0005179) |
0.4 | 1.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.4 | 28.3 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.4 | 0.4 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.4 | 0.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.4 | 1.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.4 | 1.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.4 | 1.9 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.4 | 2.7 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.4 | 0.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.4 | 0.8 | GO:2001069 | glycogen binding(GO:2001069) |
0.4 | 2.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.4 | 3.7 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.4 | 12.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.4 | 1.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.4 | 0.4 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.4 | 0.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.3 | 7.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.3 | 0.3 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.3 | 0.3 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.3 | 2.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.3 | 1.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 6.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.3 | 0.6 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 9.6 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.3 | 0.6 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.3 | 3.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.3 | 0.6 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.3 | 1.7 | GO:0050733 | RS domain binding(GO:0050733) |
0.3 | 0.8 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.3 | 2.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 2.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.3 | 1.6 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.3 | 0.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 2.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 0.2 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
0.2 | 1.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 1.2 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.2 | 2.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 1.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 5.4 | GO:0008009 | chemokine activity(GO:0008009) |
0.2 | 0.9 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 1.5 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 0.4 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.2 | 1.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 1.4 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.2 | 4.6 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.2 | 2.3 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.2 | 0.4 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 1.5 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 0.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 0.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 1.1 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.2 | 6.4 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 1.0 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.3 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.5 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 3.3 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.0 | GO:0002046 | opsin binding(GO:0002046) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.4 | 236.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
5.9 | 64.8 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
4.5 | 191.9 | NABA COLLAGENS | Genes encoding collagen proteins |
4.3 | 81.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
4.2 | 46.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
4.1 | 98.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
4.1 | 16.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
4.0 | 52.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
4.0 | 27.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
3.7 | 84.7 | PID REELIN PATHWAY | Reelin signaling pathway |
3.4 | 47.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
3.3 | 46.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
3.3 | 36.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
3.2 | 3.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
3.1 | 71.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
3.0 | 36.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
3.0 | 90.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
3.0 | 98.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
3.0 | 101.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
3.0 | 29.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
2.9 | 91.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
2.9 | 37.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
2.7 | 24.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
2.6 | 71.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
2.6 | 116.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
2.6 | 39.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
2.5 | 45.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
2.5 | 63.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
2.5 | 50.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
2.5 | 2.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
2.5 | 402.8 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
2.5 | 49.9 | PID RAS PATHWAY | Regulation of Ras family activation |
2.5 | 19.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
2.4 | 31.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
2.3 | 42.0 | PID SHP2 PATHWAY | SHP2 signaling |
2.2 | 10.9 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
2.1 | 32.0 | PID ENDOTHELIN PATHWAY | Endothelins |
2.1 | 78.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
2.1 | 33.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
2.1 | 37.1 | PID ALK1 PATHWAY | ALK1 signaling events |
2.0 | 33.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
2.0 | 15.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.8 | 5.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.7 | 19.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
1.7 | 226.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
1.7 | 18.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.7 | 13.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.7 | 25.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
1.6 | 33.6 | PID FGF PATHWAY | FGF signaling pathway |
1.6 | 83.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
1.5 | 3.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
1.4 | 4.3 | PID S1P S1P3 PATHWAY | S1P3 pathway |
1.4 | 29.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
1.3 | 329.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
1.3 | 22.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.2 | 250.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
1.1 | 18.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
1.1 | 7.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.1 | 10.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.9 | 12.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.9 | 8.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.8 | 11.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.7 | 0.7 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.6 | 0.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.6 | 13.0 | PID BMP PATHWAY | BMP receptor signaling |
0.6 | 2.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.6 | 18.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.6 | 13.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.4 | 7.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.4 | 11.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.4 | 2.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 3.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 1.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.3 | 3.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 2.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 0.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 1.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 1.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.2 | 12.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
11.7 | 151.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
9.5 | 123.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
9.0 | 17.9 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
8.7 | 131.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
7.1 | 162.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
7.1 | 84.6 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
6.4 | 69.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
6.1 | 140.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
5.8 | 251.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
5.8 | 224.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
5.6 | 89.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
5.5 | 16.5 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
5.3 | 42.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
5.1 | 96.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
5.0 | 39.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
4.7 | 51.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
4.6 | 55.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
4.6 | 50.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
4.4 | 4.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
4.3 | 98.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
4.1 | 174.1 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
4.1 | 148.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
4.1 | 4.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
3.9 | 15.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
3.7 | 37.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
3.7 | 7.4 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
3.6 | 40.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
3.5 | 67.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
3.5 | 109.3 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
3.5 | 27.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
3.5 | 24.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
3.4 | 3.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
3.4 | 73.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
3.3 | 26.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
3.2 | 35.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
3.1 | 34.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
3.1 | 37.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
3.0 | 3.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
2.7 | 32.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
2.7 | 34.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
2.6 | 2.6 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
2.5 | 22.3 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
2.5 | 29.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
2.4 | 30.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
2.3 | 44.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
2.3 | 6.9 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
2.3 | 18.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
2.2 | 4.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
2.0 | 4.0 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
2.0 | 27.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
1.9 | 22.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.9 | 5.7 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
1.8 | 14.8 | REACTOME OPSINS | Genes involved in Opsins |
1.8 | 5.5 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
1.8 | 8.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.7 | 14.0 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
1.7 | 27.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
1.6 | 28.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
1.6 | 3.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
1.6 | 3.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
1.6 | 6.4 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
1.6 | 16.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
1.6 | 10.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
1.5 | 28.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.5 | 23.8 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
1.4 | 14.4 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
1.4 | 4.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.4 | 13.8 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
1.4 | 20.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
1.3 | 3.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.3 | 5.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
1.2 | 27.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
1.2 | 34.4 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
1.2 | 9.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.2 | 5.9 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
1.2 | 14.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
1.2 | 74.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
1.2 | 30.3 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
1.1 | 9.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.1 | 15.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
1.1 | 72.4 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
1.1 | 29.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
1.0 | 3.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
1.0 | 5.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.0 | 1.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.9 | 9.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.9 | 14.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.8 | 5.9 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.8 | 8.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.8 | 9.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.7 | 4.5 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.7 | 11.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.7 | 6.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.7 | 10.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.7 | 5.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.7 | 3.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.7 | 14.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.7 | 2.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.6 | 65.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.6 | 11.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.6 | 12.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.6 | 7.0 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.6 | 2.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.6 | 7.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.6 | 11.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.6 | 19.7 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.6 | 4.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.6 | 4.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.6 | 4.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.6 | 7.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.5 | 35.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.5 | 0.5 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.5 | 5.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.5 | 7.1 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.5 | 3.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.5 | 7.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.4 | 7.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.4 | 7.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.4 | 3.6 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.4 | 1.8 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.4 | 4.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.3 | 5.8 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.3 | 1.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.3 | 3.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.3 | 1.0 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 5.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 0.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 5.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.2 | 1.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 1.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 0.7 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 7.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 2.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 0.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 1.3 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 0.1 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.1 | 1.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 2.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 3.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 0.4 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 4.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.3 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |